Direct	O
demonstration	O
of	O
NFATp	B-protein
dephosphorylation	O
and	O
nuclear	O
localization	O
in	O
activated	B-cell_line
HT-2	I-cell_line
cells	I-cell_line
using	O
a	O
specific	O
NFATp	B-protein
polyclonal	I-protein
antibody	I-protein
.	O

Nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
(	O
NFAT	B-protein
)	O
regulates	O
transcription	O
of	O
a	O
number	O
of	O
cytokine	B-protein
genes	I-protein
,	O
and	O
NFAT	B-protein
DNA	O
binding	O
activity	O
is	O
stimulated	O
following	O
T	O
cell	O
activation	O
.	O

Several	O
lines	O
of	O
evidence	O
have	O
suggested	O
that	O
NFAT	B-protein
is	O
a	O
substrate	O
for	O
calcineurin	B-protein
,	O
a	O
serine/threonine	B-protein
phosphatase	I-protein
.	O

Using	O
a	O
polyclonal	O
antibody	O
to	O
murine	B-protein
NFATp	I-protein
,	O
Western	O
blot	O
analysis	O
of	O
various	O
mouse	O
tissues	O
demonstrated	O
that	O
the	O
110-130-kDa	O
NFATp	B-protein
protein	I-protein
was	O
highly	O
expressed	O
in	O
thymus	O
and	O
spleen	O
.	O

Treatment	O
of	O
immunoprecipitated	O
NFATp	B-protein
from	O
untreated	O
HT-2	B-cell_line
cells	I-cell_line
with	O
calcineurin	B-protein
resulted	O
in	O
the	O
dephosphorylation	O
of	O
NFATp	B-protein
,	O
demonstrating	O
that	O
NFATp	B-protein
is	O
an	O
in	O
vitro	O
substrate	O
for	O
calcineurin	B-protein
.	O

NFATp	B-protein
immunoprecipitated	O
from	O
32P-labeled	B-cell_line
HT-2	I-cell_line
cells	I-cell_line
migrated	O
as	O
an	O
approximately	O
120-kDa	O
protein	O
that	O
was	O
localized	O
to	O
the	O
cytosol	O
of	O
the	O
cells	O
.	O

Treatment	O
of	O
the	O
cells	O
with	O
ionomycin	O
resulted	O
in	O
a	O
decrease	O
in	O
the	O
molecular	O
weight	O
of	O
NFATp	B-protein
and	O
a	O
loss	O
of	O
32P	O
,	O
consistent	O
with	O
NFATp	B-protein
dephosphorylation	O
.	O

The	O
dephosphorylation	O
of	O
NFATp	B-protein
was	O
accompanied	O
by	O
localization	O
of	O
the	O
protein	O
to	O
the	O
nuclear	O
fraction	O
.	O

Both	O
of	O
these	O
events	O
were	O
blocked	O
by	O
preincubation	O
of	O
the	O
cells	O
with	O
FK506	O
,	O
a	O
calcineurin	B-protein
inhibitor	O
,	O
consistent	O
with	O
the	O
hypothesis	O
that	O
NFATp	B-protein
is	O
a	O
calcineurin	B-protein
substrate	O
in	O
cells	O
.	O

THE	NULL
JoUrNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

270	NULL
,	NULL
No	NULL
.	NULL

38	NULL
,	NULL
Issue	NULL
of	NULL
September	NULL
22	NULL
,	NULL
pp	NULL
.	NULL

22602-22607	NULL
,	NULL
1995	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

Direct	NULL
Demonstration	NULL
of	NULL
NFAT	NULL
,	NULL
Dephosphorylation	NULL
and	NULL
Nuclear	NULL
Localization	NULL
in	NULL
Activated	NULL
HT-2	NULL
Cells	NULL
Using	NULL
a	NULL
Specific	NULL
NFAT	NULL
,	NULL
Polyclonal	NULL
Antibody*	NULL
Valerie	NULL
A.	NULL
Ruff	NULL
and	NULL
Karen	NULL
L.	NULL
Leacht	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
June	NULL
26	NULL
,	NULL
1995	NULL
)	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Cell	NULL
Biology	NULL
and	NULL
Inflammation	NULL
Research	NULL
,	NULL
The	NULL
Upjohn	NULL
Company	NULL
,	NULL
Kalamazoo	NULL
,	NULL
Michigan	NULL
49001	NULL
Nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
regulates	NULL
transcription	NULL
of	NULL
a	NULL
number	NULL
of	NULL
cytokine	NULL
genes	NULL
,	NULL
and	NULL
NFAT	NULL
DNA	NULL
binding	NULL
activity	NULL
is	NULL
stimulated	NULL
following	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Several	NULL
lines	NULL
of	NULL
evidence	NULL
have	NULL
suggested	NULL
that	NULL
NFAT	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
calcineurin	NULL
,	NULL
a	NULL
serine/threonine	NULL
phosphatase	NULL
.	NULL

Using	NULL
a	NULL
polyclonal	NULL
antibody	NULL
to	NULL
murine	NULL
NFAT	NULL
,	NULL
,	NULL
,	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
various	NULL
mouse	NULL
tissues	NULL
demonstrated	NULL
that	NULL
the	NULL
110-130-kDa	NULL
NFAT	NULL
,	NULL
,	NULL
protein	NULL
was	NULL
highly	NULL
expressed	NULL
in	NULL
thymus	NULL
and	NULL
spleen	NULL
.	NULL

Treatment	NULL
of	NULL
immunoprecipitated	NULL
NFAT	NULL
,	NULL
,	NULL
from	NULL
untreated	NULL
HT-2	NULL
cells	NULL
with	NULL
calcineurin	NULL
resulted	NULL
in	NULL
the	NULL
dephosphorylation	NULL
of	NULL
NFAT	NULL
,	NULL
,	NULL
,	NULL
demonstrating	NULL
that	NULL
NFAT	NULL
,	NULL
is	NULL
an	NULL
in	NULL
vitro	NULL
substrate	NULL
for	NULL
calcineurin	NULL
.	NULL

NFAT	NULL
,	NULL
,	NULL
immunoprecipitated	NULL
from	NULL
P-labeled	NULL
HT-2	NULL
cells	NULL
migrated	NULL
as	NULL
an	NULL
approximately	NULL
120-kDa	NULL
protein	NULL
that	NULL
was	NULL
localized	NULL
to	NULL
the	NULL
cytosol	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

Treatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
ionomycin	NULL
resulted	NULL
in	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
molecular	NULL
weight	NULL
of	NULL
NFAT	NULL
,	NULL
,	NULL
and	NULL
a	NULL
loss	NULL
of	NULL
*°P	NULL
,	NULL
consistent	NULL
with	NULL
NFAT	NULL
,	NULL
,	NULL
dephosphorylation	NULL
.	NULL

The	NULL
dephosphorylation	NULL
of	NULL
NFAT	NULL
,	NULL
was	NULL
accompanied	NULL
by	NULL
localization	NULL
of	NULL
the	NULL
protein	NULL
to	NULL
the	NULL
nuclear	NULL
fraction	NULL
.	NULL

Both	NULL
of	NULL
these	NULL
events	NULL
were	NULL
blocked	NULL
by	NULL
preincubation	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
FK506	NULL
,	NULL
a	NULL
calcineurin	NULL
inhibitor	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
hypothesis	NULL
that	NULL
NFAT	NULL
,	NULL
is	NULL
a	NULL
calcineurin	NULL
substrate	NULL
in	NULL
cells	NULL
.	NULL

The	NULL
immunosuppressant	NULL
drugs	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
``	NULL
and	NULL
FK506	NULL
inhibit	NULL
the	NULL
early	NULL
steps	NULL
of	NULL
antigen-stimulated	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

These	NULL
drugs	NULL
prevent	NULL
activation	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
cytokine	NULL
genes	NULL
,	NULL
including	NULL
IL-2	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimu-lating	NULL
factor	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Refs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

IL-2	NULL
plays	NULL
a	NULL
key	NULL
role	NULL
in	NULL
controlling	NULL
T	NULL
cell	NULL
proliferation	NULL
,	NULL
and	NULL
consequently	NULL
,	NULL
numerous	NULL
studies	NULL
have	NULL
focussed	NULL
on	NULL
understanding	NULL
IL-2	NULL
gene	NULL
regulation	NULL
.	NULL

The	NULL
results	NULL
of	NULL
these	NULL
studies	NULL
demonstrated	NULL
that	NULL
transcriptional	NULL
activation	NULL
requires	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
,	NULL
a	NULL
DNA	NULL
binding	NULL
protein	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
specific	NULL
sites	NULL
on	NULL
the	NULL
regulatory	NULL
regions	NULL
of	NULL
the	NULL
cytokine	NULL
genes	NULL
(	NULL
3-6	NULL
)	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
biochemical	NULL
studies	NULL
have	NULL
provided	NULL
insights	NULL
into	NULL
the	NULL
actions	NULL
of	NULL
NFAT	NULL
.	NULL

The	NULL
approximately	NULL
120-kDa	NULL
NFAT	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
gene	NULL
family	NULL
whose	NULL
members	NULL
appear	NULL
to	NULL
contain	NULL
a	NULL
Rel	NULL
homology	NULL
region	NULL
,	NULL
which	NULL
is	NULL
important	NULL
for	NULL
DNA	NULL
*	NULL
The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

$	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
The	NULL
Upjohn	NULL
Company	NULL
,	NULL
7000	NULL
Portage	NULL
Rd	NULL
.	NULL

,	NULL
Kalamazoo	NULL
,	NULL
MI	NULL
49001	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
616-385-5390	NULL
;	NULL
Fax	NULL
:	NULL
616-384-9308	NULL
.	NULL

'The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
CsA	NULL
,	NULL
cyclosporin	NULL
A	NULL
;	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
CaN	NULL
,	NULL
calcineurin	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
18-acetate	NULL
;	NULL
PBS	NULL
,	NULL
phos-phate-buffered	NULL
saline	NULL
;	NULL
NFAT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

binding	NULL
activity	NULL
.	NULL

Two	NULL
members	NULL
were	NULL
identified	NULL
:	NULL
NFAT	NULL
,	NULL
was	NULL
cloned	NULL
from	NULL
a	NULL
human	NULL
T	NULL
cell	NULL
library	NULL
(	NULL
7	NULL
)	NULL
,	NULL
while	NULL
NFAT	NULL
,	NULL
was	NULL
purified	NULL
and	NULL
cloned	NULL
from	NULL
murine	NULL
T	NULL
cells	NULL
(	NULL
8	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
several	NULL
alternatively	NULL
spliced	NULL
forms	NULL
of	NULL
NFATp	NULL
were	NULL
identified	NULL
(	NULL
2	NULL
)	NULL
.	NULL

NFAT	NULL
,	NULL
and	NULL
NFAT	NULL
,	NULL
are	NULL
approximately	NULL
73	NULL
%	NULL
identical	NULL
in	NULL
the	NULL
Rel	NULL
homology	NULL
region	NULL
,	NULL
although	NULL
they	NULL
share	NULL
little	NULL
similarity	NULL
outside	NULL
that	NULL
domain	NULL
.	NULL

In	NULL
unactivated	NULL
T	NULL
cells	NULL
,	NULL
NFAT	NULL
DNA	NULL
binding	NULL
activity	NULL
is	NULL
localized	NULL
primarily	NULL
in	NULL
the	NULL
cytosol	NULL
,	NULL
and	NULL
following	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
activity	NULL
is	NULL
detected	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

Nuclear	NULL
NFAT	NULL
forms	NULL
a	NULL
complex	NULL
with	NULL
Fos	NULL
and	NULL
Jun	NULL
,	NULL
and	NULL
mutations	NULL
in	NULL
NFAT	NULL
that	NULL
inhibit	NULL
binding	NULL
to	NULL
these	NULL
proteins	NULL
eliminate	NULL
NFAT-medi-ated	NULL
gene	NULL
transcription	NULL
.	NULL

Furthermore	NULL
,	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
either	NULL
CsA	NULL
or	NULL
FK506	NULL
inhibits	NULL
the	NULL
appearance	NULL
of	NULL
NFAT	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
nucleus	NULL
(	NULL
8	NULL
,	NULL
9-11	NULL
)	NULL
.	NULL

An	NULL
understanding	NULL
of	NULL
the	NULL
link	NULL
between	NULL
the	NULL
drugs	NULL
FK506	NULL
and	NULL
CsA	NULL
and	NULL
NFAT	NULL
has	NULL
recently	NULL
started	NULL
to	NULL
emerge	NULL
with	NULL
the	NULL
identification	NULL
of	NULL
calcineurin	NULL
(	NULL
CaN	NULL
)	NULL
as	NULL
a	NULL
cellular	NULL
target	NULL
of	NULL
the	NULL
drugs	NULL
.	NULL

FK506	NULL
and	NULL
CsA	NULL
bind	NULL
to	NULL
their	NULL
respective	NULL
immunophilins	NULL
,	NULL
FKBP-12	NULL
and	NULL
cyclophilin	NULL
A	NULL
,	NULL
and	NULL
the	NULL
drug-immunophilin	NULL
complexes	NULL
bind	NULL
to	NULL
and	NULL
inhibit	NULL
the	NULL
activity	NULL
of	NULL
CaN	NULL
,	NULL
a	NULL
calmodulin-de-pendent	NULL
phosphatase	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
a	NULL
constitutively	NULL
active	NULL
form	NULL
of	NULL
CaN	NULL
in	NULL
T	NULL
cells	NULL
renders	NULL
the	NULL
cells	NULL
more	NULL
resistant	NULL
to	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
drugs	NULL
,	NULL
and	NULL
the	NULL
ability	NULL
of	NULL
a	NULL
number	NULL
of	NULL
FK506	NULL
and	NULL
CsA	NULL
analogues	NULL
to	NULL
inhibit	NULL
the	NULL
phosphatase	NULL
activity	NULL
of	NULL
CaN	NULL
correlates	NULL
with	NULL
their	NULL
ability	NULL
to	NULL
inhibit	NULL
T	NULL
cell	NULL
activation	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Evidence	NULL
suggests	NULL
that	NULL
CaN	NULL
is	NULL
not	NULL
just	NULL
involved	NULL
in	NULL
mediating	NULL
the	NULL
actions	NULL
of	NULL
FK506	NULL
and	NULL
CsA	NULL
but	NULL
that	NULL
the	NULL
enzyme	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
the	NULL
physiological	NULL
pathway	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

O'Keefe	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
15	NULL
)	NULL
demonstrated	NULL
that	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
CaN	NULL
,	NULL
PMA-and	NULL
ionophore-stimulated	NULL
IL-2-driven	NULL
gene	NULL
expression	NULL
was	NULL
stimulated	NULL
approximately	NULL
2-fold	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
cells	NULL
overex-pressing	NULL
a	NULL
constitutively	NULL
active	NULL
form	NULL
of	NULL
CaN	NULL
,	NULL
IL-2-driven	NULL
gene	NULL
expression	NULL
was	NULL
stimulated	NULL
approximately	NULL
150-fold	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
alone	NULL
,	NULL
indicating	NULL
that	NULL
active	NULL
CaN	NULL
can	NULL
replace	NULL
the	NULL
usual	NULL
requirement	NULL
for	NULL
ionophore	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
by	NULL
Clipstone	NULL
and	NULL
Crabtree	NULL
(	NULL
16	NULL
)	NULL
,	NULL
who	NULL
demonstrated	NULL
reporter	NULL
gene	NULL
activity	NULL
in	NULL
CaN-transfected	NULL
cells	NULL
at	NULL
suboptimal	NULL
concentrations	NULL
of	NULL
ionomycin	NULL
that	NULL
elicited	NULL
little	NULL
or	NULL
no	NULL
activity	NULL
in	NULL
control	NULL
cells	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
demonstrate	NULL
that	NULL
CaN	NULL
overexpression	NULL
augments	NULL
T	NULL
cell	NULL
activation	NULL
resulting	NULL
from	NULL
both	NULL
calcium	NULL
and	NULL
PKC	NULL
stimulation	NULL
and	NULL
suggest	NULL
that	NULL
CaN	NULL
plays	NULL
a	NULL
key	NULL
role	NULL
in	NULL
this	NULL
process	NULL
.	NULL

The	NULL
studies	NULL
with	NULL
CsA	NULL
and	NULL
FK506	NULL
led	NULL
to	NULL
the	NULL
suggestion	NULL
that	NULL
NFAT	NULL
is	NULL
a	NULL
CaN	NULL
substrate	NULL
,	NULL
either	NULL
direct	NULL
or	NULL
indirect	NULL
,	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

First	NULL
,	NULL
indirect	NULL
evidence	NULL
indicates	NULL
that	NULL
NFAT	NULL
,	NULL
is	NULL
a	NULL
phosphoprotein	NULL
.	NULL

Fractionation	NULL
of	NULL
Jurkat	NULL
cell	NULL
cytosol	NULL
demonstrated	NULL
that	NULL
NFAT	NULL
DNA	NULL
binding	NULL
activity	NULL
is	NULL
detected	NULL
with	NULL
proteins	NULL
in	NULL
a	NULL
molecular	NULL
mass	NULL
range	NULL
of	NULL
94-116	NULL
kDa	NULL
,	NULL
suggesting	NULL
heterogeneity	NULL
in	NULL
the	NULL
size	NULL
of	NULL
the	NULL
NFAT	NULL
protein	NULL
(	NULL
17	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
22602	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
NFAT	NULL
,	NULL
Dephosphorylation	NULL
and	NULL
Nuclear	NULL
Localization	NULL
NFAT	NULL
phosphorylation	NULL
could	NULL
explain	NULL
the	NULL
heterogeneity	NULL
,	NULL
McCaffrey	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
18	NULL
)	NULL
treated	NULL
cell	NULL
extracts	NULL
enriched	NULL
for	NULL
NFAT	NULL
with	NULL
alkaline	NULL
phosphatase	NULL
.	NULL

This	NULL
enzymatic	NULL
treatment	NULL
resulted	NULL
in	NULL
a	NULL
shift	NULL
in	NULL
NFAT	NULL
binding	NULL
activity	NULL
from	NULL
the	NULL
127-143-kDa	NULL
molecular	NULL
weight	NULL
fraction	NULL
to	NULL
a	NULL
101-113-kDa	NULL
fraction	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
hypothesis	NULL
that	NULL
NFAT	NULL
is	NULL
a	NULL
phosphoprotein	NULL
.	NULL

Sec-ond	NULL
,	NULL
treatment	NULL
of	NULL
purified	NULL
NFAT	NULL
with	NULL
purified	NULL
bovine	NULL
brain	NULL
CaN	NULL
also	NULL
resulted	NULL
in	NULL
a	NULL
shift	NULL
in	NULL
the	NULL
molecular	NULL
weight	NULL
of	NULL
NFAT	NULL
,	NULL
suggesting	NULL
that	NULL
NFAT	NULL
is	NULL
an	NULL
in	NULL
vitro	NULL
substrate	NULL
for	NULL
CaN	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Whether	NULL
NFAT	NULL
is	NULL
a	NULL
direct	NULL
CaN	NULL
substrate	NULL
in	NULL
intact	NULL
cells	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
determined	NULL
,	NULL
however	NULL
.	NULL

In	NULL
the	NULL
majority	NULL
of	NULL
reported	NULL
NFAT	NULL
studies	NULL
,	NULL
NFAT	NULL
DNA	NULL
binding	NULL
activity	NULL
has	NULL
been	NULL
the	NULL
end	NULL
point	NULL
usually	NULL
measured	NULL
,	NULL
since	NULL
relatively	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
NFAT	NULL
protein	NULL
.	NULL

However	NULL
,	NULL
the	NULL
recent	NULL
cloning	NULL
and	NULL
expression	NULL
of	NULL
NFAT	NULL
genes	NULL
has	NULL
yielded	NULL
valuable	NULL
information	NULL
about	NULL
the	NULL
proteins	NULL
,	NULL
and	NULL
direct	NULL
protein	NULL
analyses	NULL
should	NULL
now	NULL
be	NULL
possible	NULL
.	NULL

Towards	NULL
that	NULL
end	NULL
,	NULL
antibodies	NULL
to	NULL
NFAT	NULL
will	NULL
be	NULL
important	NULL
reagents	NULL
to	NULL
develop	NULL
for	NULL
probing	NULL
protein	NULL
structure	NULL
and	NULL
function	NULL
.	NULL

In	NULL
the	NULL
studies	NULL
reported	NULL
here	NULL
,	NULL
we	NULL
developed	NULL
a	NULL
peptide	NULL
antibody	NULL
to	NULL
NFAT	NULL
,	NULL
and	NULL
we	NULL
used	NULL
it	NULL
to	NULL
characterize	NULL
NFAT	NULL
,	NULL
in	NULL
cells	NULL
.	NULL

We	NULL
demonstrate	NULL
directly	NULL
in	NULL
°°P	NULL
labeling	NULL
experiments	NULL
that	NULL
NFAT	NULL
,	NULL
is	NULL
a	NULL
phosphoprotein	NULL
and	NULL
that	NULL
T	NULL
cell	NULL
activation	NULL
results	NULL
in	NULL
NFAT	NULL
,	NULL
dephosphorylation	NULL
that	NULL
can	NULL
be	NULL
blocked	NULL
by	NULL
pretreatment	NULL
with	NULL
FK506	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
show	NULL
that	NULL
dephosphorylation	NULL
is	NULL
accompanied	NULL
by	NULL
translocation	NULL
of	NULL
NFAT	NULL
,	NULL
protein	NULL
from	NULL
the	NULL
cytosol	NULL
to	NULL
the	NULL
nucleus	NULL
of	NULL
cells	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Materials-FK506	NULL
and	NULL
rapamycin	NULL
were	NULL
prepared	NULL
at	NULL
the	NULL
Upjohn	NULL
Company	NULL
from	NULL
fermentation	NULL
broths	NULL
of	NULL
Streptomyces	NULL
tsukubaenis	NULL
(	NULL
Upjohn	NULL
Culture	NULL
Collection	NULL
11052	NULL
)	NULL
and	NULL
Streptomyces	NULL
hygroscopicus	NULL
(	NULL
Upjohn	NULL
Collection	NULL
5931	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

CaN	NULL
and	NULL
calmodulin	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
,	NULL
and	NULL
PP2a	NULL
was	NULL
from	NULL
UBI	NULL
.	NULL

[	NULL
°°P	NULL
]	NULL
Orthophosphate	NULL
was	NULL
obtained	NULL
from	NULL
DuPont	NULL
NEN	NULL
.	NULL

Protein	NULL
A-Sepharose	NULL
CL-4B	NULL
beads	NULL
were	NULL
from	NULL
Phar-macia	NULL
Biotech	NULL
Inc.	NULL
[	NULL
*°S	NULL
]	NULL
Methionine	NULL
and	NULL
ECL	NULL
reagents	NULL
were	NULL
obtained	NULL
from	NULL
Amersham	NULL
Corp.	NULL
Tyrosine	NULL
phosphatase	NULL
PTP1	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
John	NULL
Bleasdale	NULL
(	NULL
The	NULL
Upjohn	NULL
Company	NULL
)	NULL
.	NULL

CaN	NULL
autoinhibitory	NULL
peptide	NULL
(	NULL
22	NULL
)	NULL
was	NULL
synthesized	NULL
at	NULL
The	NULL
Upjohn	NULL
Company	NULL
.	NULL

Cell	NULL
Culture-The	NULL
human	NULL
T	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
J5D9	NULL
and	NULL
HSB	NULL
and	NULL
the	NULL
murine	NULL
T	NULL
lymphoma	NULL
cell	NULL
line	NULL
EL-4	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
100	NULL
units/ml	NULL
penicillin	NULL
G	NULL
,	NULL
and	NULL
100	NULL
ug/ml	NULL
streptomycin	NULL
.	NULL

The	NULL
murine	NULL
helper	NULL
T	NULL
cell	NULL
line	NULL
HT-2	NULL
was	NULL
grown	NULL
in	NULL
the	NULL
medium	NULL
just	NULL
described	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
12	NULL
%	NULL
rat	NULL
T-STIM	NULL
with	NULL
concanavalin	NULL
A	NULL
as	NULL
a	NULL
source	NULL
of	NULL
IL-2	NULL
(	NULL
Collaborative	NULL
Biomedical	NULL
Products	NULL
)	NULL
,	NULL
50	NULL
pM	NULL
B-mercaptoethanol	NULL
,	NULL
and	NULL
10	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.4	NULL
.	NULL

Human	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
were	NULL
prepared	NULL
from	NULL
leu-kophoresis	NULL
packs	NULL
.	NULL

Cells	NULL
were	NULL
centrifuged	NULL
over	NULL
Ficoll	NULL
,	NULL
and	NULL
cells	NULL
at	NULL
the	NULL
interface	NULL
were	NULL
collected	NULL
,	NULL
diluted	NULL
with	NULL
RPMI	NULL
,	NULL
and	NULL
pelleted	NULL
.	NULL

The	NULL
cell	NULL
pellet	NULL
was	NULL
suspended	NULL
in	NULL
RPMI	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Nonadherent	NULL
cells	NULL
were	NULL
collected	NULL
,	NULL
pelleted	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-70	NULL
°C	NULL
.	NULL

Antibody	NULL
Production-The	NULL
amino	NULL
acids	NULL
CGG	NULL
were	NULL
added	NULL
to	NULL
the	NULL
amino	NULL
terminus	NULL
of	NULL
the	NULL
sequence	NULL
LSPGAYPTVIQQQTAPSQR	NULL
corresponding	NULL
to	NULL
peptide	NULL
25	NULL
of	NULL
NFAT	NULL
,	NULL
(	NULL
8	NULL
)	NULL
.	NULL

The	NULL
cysteine	NULL
residue	NULL
was	NULL
coupled	NULL
to	NULL
maleimide-activated	NULL
KLH	NULL
using	NULL
the	NULL
Imject	NULL
Immunogen	NULL
Conjugation	NULL
Kit	NULL
(	NULL
Pierce	NULL
)	NULL
,	NULL
and	NULL
rabbits	NULL
were	NULL
injected	NULL
.	NULL

Sera	NULL
was	NULL
tested	NULL
against	NULL
purified	NULL
peptide	NULL
,	NULL
and	NULL
bleeds	NULL
determined	NULL
to	NULL
have	NULL
the	NULL
highest	NULL
titer	NULL
were	NULL
affinity-purified	NULL
by	NULL
using	NULL
the	NULL
Pierce	NULL
Ag/Ab	NULL
immobilization	NULL
kit	NULL
with	NULL
Sulfolink	NULL
coupling	NULL
gel	NULL
.	NULL

The	NULL
antibody	NULL
preparation	NULL
used	NULL
in	NULL
the	NULL
experiments	NULL
shown	NULL
here	NULL
recognized	NULL
1	NULL
ng	NULL
of	NULL
purified	NULL
peptide	NULL
at	NULL
a	NULL
1:1000	NULL
dilution	NULL
.	NULL

Tissue	NULL
Homogenates-Homogenates	NULL
were	NULL
prepared	NULL
from	NULL
organs	NULL
dissected	NULL
from	NULL
BALB/C	NULL
mice	NULL
as	NULL
described	NULL
in	NULL
Ref	NULL
.	NULL

20	NULL
using	NULL
a	NULL
Polytron	NULL
homogenizer	NULL
.	NULL

The	NULL
tissues	NULL
were	NULL
homogenized	NULL
at	NULL
0.3	NULL
g	NULL
wet	NULL
weight/ml	NULL
in	NULL
10	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
containing	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
100	NULL
ug/ml	NULL
aprotinin	NULL
and	NULL
soybean	NULL
trypsin	NULL
inhibitor	NULL
,	NULL
250	NULL
uM	NULL
leupeptin	NULL
,	NULL
10	NULL
mM	NULL
iodoacetamide	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
.	NULL

SDS	NULL
was	NULL
added	NULL
to	NULL
bring	NULL
the	NULL
final	NULL
concentration	NULL
to	NULL
2	NULL
%	NULL
.	NULL

The	NULL
sample	NULL
was	NULL
heated	NULL
at	NULL
100	NULL
°C	NULL
for	NULL
10	NULL
min	NULL
and	NULL
then	NULL
centrifuged	NULL
for	NULL
10	NULL
min	NULL
in	NULL
a	NULL
microfuge	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
removed	NULL
,	NULL
and	NULL
protein	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
microas-say	NULL
method	NULL
of	NULL
Bradford	NULL
(	NULL
21	NULL
)	NULL
using	NULL
reagents	NULL
from	NULL
Bio-Rad	NULL
.	NULL

Cellular	NULL
Fractionation-Treatment	NULL
of	NULL
HT-2	NULL
cells	NULL
(	NULL
1	NULL
X	NULL
10°	NULL
cells/condition	NULL
)	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
.	NULL

The	NULL
cells	NULL
then	NULL
were	NULL
washed	NULL
in	NULL
ice-cold	NULL
PBS	NULL
and	NULL
resuspended	NULL
(	NULL
2.5	NULL
X	NULL
10°	NULL
cells/ml	NULL
)	NULL
in	NULL
22603	NULL
buffer	NULL
(	NULL
10	NULL
mm	NULL
Tris-Cl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
containing	NULL
10	NULL
mM	NULL
NaCl	NULL
,	NULL
3	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.1	NULL
mM	NULL
EGTA	NULL
,	NULL
2	NULL
um	NULL
leupeptin	NULL
,	NULL
1	NULL
pg/ml	NULL
aprotinin	NULL
,	NULL
and	NULL
0.05	NULL
%	NULL
Nonidet	NULL
P-40	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
centrifuged	NULL
at	NULL
650	NULL
x	NULL
g	NULL
to	NULL
pellet	NULL
the	NULL
nuclei	NULL
,	NULL
and	NULL
the	NULL
supernatant	NULL
was	NULL
removed	NULL
.	NULL

The	NULL
nuclear	NULL
pellet	NULL
was	NULL
washed	NULL
in	NULL
the	NULL
above	NULL
buffer	NULL
minus	NULL
detergent	NULL
,	NULL
and	NULL
the	NULL
final	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
Laemmli	NULL
buffer	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
recentrifuged	NULL
to	NULL
remove	NULL
any	NULL
residual	NULL
nu-clei	NULL
.	NULL

Equal	NULL
cell	NULL
equivalents	NULL
of	NULL
soluble	NULL
and	NULL
nuclear	NULL
fractions	NULL
were	NULL
electrophoresed	NULL
on	NULL
6	NULL
%	NULL
SDS-polyacrylamide	NULL
gels	NULL
,	NULL
and	NULL
Western	NULL
blotting	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
below	NULL
.	NULL

Western	NULL
Blots-Cells	NULL
were	NULL
treated	NULL
(	NULL
2.5	NULL
X	NULL
10°	NULL
cells/condition	NULL
)	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
,	NULL
and	NULL
control	NULL
cells	NULL
received	NULL
Me	NULL
,	NULL
SO	NULL
as	NULL
a	NULL
vehicle	NULL
.	NULL

Following	NULL
treatment	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
ice-cold	NULL
PBS	NULL
and	NULL
resuspended	NULL
in	NULL
40	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
containing	NULL
10	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
60	NULL
mM	NULL
sodium	NULL
pyrophosphate	NULL
.	NULL

SDS	NULL
was	NULL
added	NULL
to	NULL
bring	NULL
the	NULL
final	NULL
concentration	NULL
to	NULL
5	NULL
%	NULL
.	NULL

The	NULL
sample	NULL
was	NULL
boiled	NULL
for	NULL
15	NULL
min	NULL
and	NULL
electrophoresed	NULL
on	NULL
a	NULL
6	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
.	NULL

Proteins	NULL
were	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
,	NULL
and	NULL
nonspecific	NULL
sites	NULL
were	NULL
blocked	NULL
with	NULL
5	NULL
%	NULL
nonfat	NULL
dry	NULL
milk	NULL
in	NULL
PBS	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
developed	NULL
with	NULL
a	NULL
1:500	NULL
dilution	NULL
of	NULL
affinity-purified	NULL
NFAT	NULL
,	NULL
antibody	NULL
in	NULL
20	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
containing	NULL
500	NULL
mM	NULL
NaCl	NULL
and	NULL
3	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
followed	NULL
by	NULL
incubation	NULL
with	NULL
a	NULL
1:5000	NULL
dilution	NULL
of	NULL
donkey	NULL
anti-rabbit	NULL
IgG	NULL
linked	NULL
to	NULL
horseradish	NULL
peroxidase	NULL
for	NULL
1	NULL
h	NULL
(	NULL
Amersham	NULL
Corp.	NULL
)	NULL
.	NULL

Immunoreactive	NULL
proteins	NULL
were	NULL
detected	NULL
with	NULL
the	NULL
ECL	NULL
system	NULL
.	NULL

For	NULL
the	NULL
phosphotyrosine	NULL
blot	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
,	NULL
lysate	NULL
from	NULL
untreated	NULL
HT-2	NULL
cells	NULL
or	NULL
epidermal	NULL
growth	NULL
factor-treated	NULL
A481	NULL
cells	NULL
(	NULL
800	NULL
ng/ml	NULL
epidermal	NULL
growth	NULL
factor	NULL
for	NULL
15	NULL
min	NULL
)	NULL
were	NULL
probed	NULL
with	NULL
1	NULL
ug/ml	NULL
4G10	NULL
antibody	NULL
(	NULL
UBI	NULL
)	NULL
,	NULL
and	NULL
the	NULL
blot	NULL
was	NULL
developed	NULL
by	NULL
ECL	NULL
.	NULL

*P	NULL
Immunoprecipitation-HT-2	NULL
cells	NULL
at	NULL
a	NULL
density	NULL
of	NULL
1	NULL
X	NULL
10°	NULL
cells/ml	NULL
were	NULL
grown	NULL
overnight	NULL
in	NULL
growth	NULL
medium	NULL
as	NULL
described	NULL
above	NULL
except	NULL
that	NULL
the	NULL
medium	NULL
contained	NULL
2	NULL
%	NULL
of	NULL
the	NULL
usual	NULL
phosphate	NULL
concentration	NULL
and	NULL
10	NULL
%	NULL
dialyzed	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
fresh	NULL
medium	NULL
containing	NULL
100	NULL
mCi/ml	NULL
[	NULL
*°PJorthophosphate	NULL
.	NULL

Cells	NULL
were	NULL
ali-quoted	NULL
at	NULL
1.5	NULL
x	NULL
10°	NULL
cells/condition	NULL
,	NULL
and	NULL
treatments	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
allowed	NULL
to	NULL
incorporate	NULL
radiolabel	NULL
for	NULL
a	NULL
total	NULL
time	NULL
of	NULL
4	NULL
h.	NULL
After	NULL
2.8	NULL
h	NULL
of	NULL
incubation	NULL
,	NULL
FK506	NULL
(	NULL
500	NULL
nM	NULL
)	NULL
was	NULL
added	NULL
for	NULL
1	NULL
h	NULL
,	NULL
followed	NULL
by	NULL
ionomycin	NULL
(	NULL
2	NULL
uM	NULL
)	NULL
for	NULL
an	NULL
additional	NULL
10	NULL
min	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
ice-cold	NULL
PBS	NULL
and	NULL
lysed	NULL
in	NULL
radioimmune	NULL
precipitation	NULL
buffer	NULL
(	NULL
10	NULL
mm	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
containing	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
1	NULL
%	NULL
deoxycholate	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
and	NULL
150	NULL
mM	NULL
NaC	NULL
)	NULL
)	NULL
containing	NULL
60	NULL
mM	NULL
sodium	NULL
pyrophosphate	NULL
and	NULL
10	NULL
mM	NULL
EDTA	NULL
.	NULL

The	NULL
sample	NULL
was	NULL
precleared	NULL
with	NULL
Protein	NULL
A-Sepharose	NULL
CL-4B	NULL
beads	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

SDS	NULL
was	NULL
added	NULL
(	NULL
0.3	NULL
%	NULL
final	NULL
concentration	NULL
)	NULL
,	NULL
and	NULL
10	NULL
pl	NULL
of	NULL
affinity-purified	NULL
antibody	NULL
was	NULL
added	NULL
to	NULL
the	NULL
sample	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
followed	NULL
by	NULL
Protein	NULL
A	NULL
for	NULL
1	NULL
h.	NULL
The	NULL
Protein	NULL
A	NULL
beads	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
radioimmune	NULL
precipitation	NULL
buffer	NULL
containing	NULL
500	NULL
mM	NULL
NaCl	NULL
and	NULL
2	NULL
mg/ml	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
followed	NULL
by	NULL
three	NULL
washes	NULL
in	NULL
radioimmune	NULL
precipitation	NULL
buffer	NULL
containing	NULL
0.3	NULL
%	NULL
SDS	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
final	NULL
wash	NULL
in	NULL
radioimmune	NULL
precipitation	NULL
buffer	NULL
.	NULL

The	NULL
sample	NULL
was	NULL
resuspended	NULL
in	NULL
Laemmli	NULL
buffer	NULL
and	NULL
electrophoresed	NULL
on	NULL
a	NULL
6	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
followed	NULL
by	NULL
autora-diography	NULL
.	NULL

The	NULL
autorad	NULL
was	NULL
quantitated	NULL
on	NULL
a	NULL
Molecular	NULL
Dynamics	NULL
PhosphorImager	NULL
using	NULL
ImageQuant	NULL
Software	NULL
.	NULL

Immunocomplex	NULL
Assays-Unlabeled	NULL
cells	NULL
(	NULL
1.5	NULL
X	NULL
10°	NULL
cells/condition	NULL
)	NULL
were	NULL
untreated	NULL
or	NULL
stimulated	NULL
for	NULL
10	NULL
min	NULL
with	NULL
2	NULL
pM	NULL
ionomycin	NULL
,	NULL
immunoprecipitated	NULL
as	NULL
described	NULL
above	NULL
,	NULL
and	NULL
washed	NULL
five	NULL
times	NULL
in	NULL
assay	NULL
buffer	NULL
(	NULL
40	NULL
mm	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
containing	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
0.5	NULL
mm	NULL
CaCl	NULL
,	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.1	NULL
mg/ml	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
1	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
and	NULL
0.1	NULL
mm	NULL
MnCl	NULL
)	NULL
.	NULL

The	NULL
immunoprecipitate	NULL
from	NULL
untreated	NULL
cells	NULL
was	NULL
incubated	NULL
in	NULL
assay	NULL
buffer	NULL
containing	NULL
the	NULL
enzymes	NULL
and	NULL
inhibitors	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
Fig	NULL
.	NULL

34	NULL
legend	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
100	NULL
wl	NULL
for	NULL
30	NULL
min	NULL
at	NULL
30	NULL
°C	NULL
.	NULL

50	NULL
pl	NULL
of	NULL
Laemmli	NULL
buffer	NULL
was	NULL
added	NULL
,	NULL
the	NULL
sample	NULL
was	NULL
boiled	NULL
,	NULL
and	NULL
the	NULL
Sepharose	NULL
beads	NULL
were	NULL
pelleted	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
electrophoresed	NULL
on	NULL
a	NULL
6	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
,	NULL
and	NULL
Western	NULL
blotting	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
above	NULL
.	NULL

Phosphatase	NULL
Assays-The	NULL
phosphatase	NULL
activity	NULL
of	NULL
CaN	NULL
and	NULL
PP2A	NULL
was	NULL
measured	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
100	NULL
pl	NULL
containing	NULL
40	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
8.6	NULL
,	NULL
100	NULL
mm	NULL
NaCl	NULL
,	NULL
0.5	NULL
mm	NULL
CaCl	NULL
,	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.1	NULL
mg/ml	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
10	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
600	NULL
pM	NULL
4-methylumbelliferryl	NULL
phosphate	NULL
and	NULL
either	NULL
25	NULL
nm	NULL
CaN	NULL
or	NULL
0.1	NULL
units	NULL
of	NULL
PP2A	NULL
.	NULL

To	NULL
measure	NULL
CaN	NULL
activity	NULL
,	NULL
assays	NULL
also	NULL
included	NULL
100	NULL
nM	NULL
calmodulin	NULL
and	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
100	NULL
uM	NULL
inhibitory	NULL
peptide	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37	NULL
°C	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
50	NULL
ul	NULL
of	NULL
stop	NULL
buffer	NULL
(	NULL
800	NULL
mM	NULL
glycine	NULL
,	NULL
pH	NULL
11.2	NULL
,	NULL
containing	NULL
15	NULL
mM	NULL
EDTA	NULL
)	NULL
,	NULL
and	NULL
the	NULL
fluorescence	NULL
was	NULL
read	NULL
at	NULL
365/405	NULL
nm	NULL
.	NULL

[	NULL
*°S	NULL
[	NULL
Methionine	NULL
Pulse-Chase-Cells	NULL
were	NULL
resuspended	NULL
at	NULL
3	NULL
X	NULL
10°	NULL
cells/ml	NULL
for	NULL
30	NULL
min	NULL
in	NULL
growth	NULL
medium	NULL
containing	NULL
2	NULL
%	NULL
of	NULL
the	NULL
usual	NULL
methionine	NULL
plus	NULL
10	NULL
%	NULL
dialyzed	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
2	NULL
uM	NULL
ionomycin	NULL
.	NULL

[	NULL
*°8	NULL
]	NULL
Methionine	NULL
was	NULL
added	NULL
at	NULL
175	NULL
uCi/ml	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
22604	NULL
A	NULL
competition	NULL
Pal	NULL
&	NULL
$	NULL
g	NULL
§	NULL
sg	NULL
8	NULL
z	NULL
8	NULL
&	NULL
a	NULL
$	NULL
E	NULL
z	NULL
8	NULL
$	NULL
91	NULL
8	NULL
g	NULL
>	NULL
Ho	NULL
&	NULL
f	NULL
>	NULL
E	NULL
m	NULL
$	NULL
§	NULL
&	NULL
%	NULL
f	NULL
!	NULL

f	NULL
fP	NULL
220-	NULL
%	NULL
&	NULL
(	NULL
b	NULL
jad	NULL
(	NULL
oO	NULL
97.4-	NULL
*	NULL
66-	NULL
-*	NULL
s	NULL
me	NULL
5	NULL
Cik	NULL
.	NULL

«	NULL
-	NULL
_-	NULL
.	NULL

Shey	NULL
dit	NULL
--	NULL
==	NULL
1oB	NULL
3	NULL
4	NULL
506	NULL
7	NULL
8	NULL
9	NULL
B	NULL
Bh	NULL
***	NULL
``	NULL
was	NULL
homed	NULL
97.4	NULL
66	NULL
-	NULL
*	NULL
me	NULL
_._	NULL
wake	NULL
I	NULL
,	NULL
E	NULL
10	NULL
20	NULL
30	NULL
40	NULL
50	NULL
60	NULL
708	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Expression	NULL
of	NULL
NFAT	NULL
,	NULL
,	NULL
in	NULL
mouse	NULL
tissues	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

Aliquots	NULL
of	NULL
mouse	NULL
tissue	NULL
homogenate	NULL
or	NULL
cell	NULL
lysates	NULL
were	NULL
prepared	NULL
,	NULL
elec-trophoresed	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
the	NULL
NFAT	NULL
,	NULL
antibody	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

The	NULL
position	NULL
of	NULL
the	NULL
molecular	NULL
weight	NULL
markers	NULL
is	NULL
as	NULL
indicated	NULL
.	NULL

A	NULL
,	NULL
200	NULL
ug	NULL
of	NULL
mouse	NULL
tissue	NULL
homogenate	NULL
from	NULL
brain	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
heart	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
kidney	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
liver	NULL
{	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
spleen	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
,	NULL
thymus	NULL
(	NULL
Zane	NULL
6	NULL
)	NULL
,	NULL
and	NULL
2.5	NULL
X	NULL
10°	NULL
HT-2	NULL
cell	NULL
equivalents	NULL
as	NULL
a	NULL
control	NULL
(	NULL
Zane	NULL
7	NULL
)	NULL
.	NULL

Lames	NULL
8	NULL
and	NULL
9	NULL
contain	NULL
spleen	NULL
and	NULL
thymus	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
the	NULL
blot	NULL
was	NULL
developed	NULL
using	NULL
antibody	NULL
containing	NULL
a	NULL
100-fold	NULL
excess	NULL
of	NULL
the	NULL
antigen	NULL
peptide	NULL
.	NULL

B	NULL
,	NULL
1	NULL
x	NULL
10°	NULL
cell	NULL
equivalents	NULL
from	NULL
J5D9	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
,	NULL
HSB	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
EL-4	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
,	NULL
2.5	NULL
X	NULL
10°	NULL
cell	NULL
equivalents	NULL
from	NULL
HT-2	NULL
cells	NULL
(	NULL
Jane	NULL
5	NULL
)	NULL
,	NULL
1	NULL
X	NULL
10°	NULL
cell	NULL
equivalents	NULL
from	NULL
EL-4	NULL
cells	NULL
(	NULL
Zane	NULL
6	NULL
)	NULL
,	NULL
and	NULL
2.5	NULL
X	NULL
10°	NULL
cell	NULL
equivalents	NULL
from	NULL
HT-2	NULL
cells	NULL
(	NULL
Zanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Lanes	NULL
6	NULL
and	NULL
7	NULL
were	NULL
developed	NULL
with	NULL
antibody	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
antigen	NULL
peptide	NULL
,	NULL
and	NULL
lane	NULL
8	NULL
was	NULL
developed	NULL
with	NULL
second	NULL
antibody	NULL
alone	NULL
.	NULL

for	NULL
5	NULL
min	NULL
,	NULL
and	NULL
1.5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
removed	NULL
for	NULL
the	NULL
zero	NULL
time	NULL
point	NULL
.	NULL

The	NULL
remainder	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
PBS	NULL
and	NULL
resuspended	NULL
in	NULL
normal	NULL
growth	NULL
medium	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
2	NULL
uM	NULL
ionomycin	NULL
.	NULL

At	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
aliquots	NULL
(	NULL
1.5	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
removed	NULL
,	NULL
lysed	NULL
,	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
the	NULL
NFAT	NULL
,	NULL
antibody	NULL
as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
autorad	NULL
was	NULL
quantitated	NULL
as	NULL
described	NULL
above	NULL
.	NULL

[	NULL
*°S/Methionine	NULL
Degradation-Cells	NULL
were	NULL
resuspended	NULL
at	NULL
6	NULL
x	NULL
10°	NULL
cells/ml	NULL
in	NULL
low	NULL
methionine-containing	NULL
medium	NULL
plus	NULL
(	NULL
50	NULL
wCi/ml	NULL
)	NULL
and	NULL
incubated	NULL
for	NULL
18	NULL
h.	NULL
The	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
PBS	NULL
and	NULL
resuspended	NULL
at	NULL
3	NULL
X	NULL
10°	NULL
cells/ml	NULL
in	NULL
normal	NULL
growth	NULL
medium	NULL
containing	NULL
Me	NULL
,	NULL
SO	NULL
(	NULL
control	NULL
)	NULL
,	NULL
2	NULL
uM	NULL
ionomycin	NULL
,	NULL
or	NULL
100	NULL
nM	NULL
FK506	NULL
plus	NULL
2	NULL
uM	NULL
ionomycin	NULL
.	NULL

Cells	NULL
were	NULL
pretreated	NULL
with	NULL
FK506	NULL
5	NULL
min	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
ionomycin	NULL
.	NULL

Cells	NULL
(	NULL
1.5	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
removed	NULL
immediately	NULL
(	NULL
zero	NULL
time	NULL
point	NULL
)	NULL
or	NULL
at	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
and	NULL
the	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Autorads	NULL
were	NULL
quantitated	NULL
as	NULL
described	NULL
above	NULL
and	NULL
analyzed	NULL
by	NULL
linear	NULL
regression	NULL
to	NULL
determine	NULL
the	NULL
NFAT	NULL
,	NULL
half-life	NULL
.	NULL

RESULTS	NULL
A	NULL
polyclonal	NULL
antibody	NULL
was	NULL
developed	NULL
against	NULL
a	NULL
peptide	NULL
from	NULL
the	NULL
COOH-terminal	NULL
domain	NULL
of	NULL
NFAT	NULL
.	NULL

This	NULL
peptide	NULL
is	NULL
outside	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
and	NULL
is	NULL
from	NULL
a	NULL
unique	NULL
region	NULL
of	NULL
NFAT	NULL
,	NULL
that	NULL
is	NULL
not	NULL
present	NULL
in	NULL
NFAT	NULL
,	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
this	NULL
antibody	NULL
is	NULL
a	NULL
specific	NULL
reagent	NULL
for	NULL
characterizing	NULL
the	NULL
NFAT	NULL
,	NULL
protein	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
order	NULL
to	NULL
determine	NULL
the	NULL
expression	NULL
of	NULL
NFAT	NULL
,	NULL
in	NULL
various	NULL
mouse	NULL
tissues	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

The	NULL
highest	NULL
level	NULL
of	NULL
NFAT	NULL
,	NULL
expression	NULL
was	NULL
observed	NULL
in	NULL
spleen	NULL
and	NULL
thymus	NULL
tissue	NULL
.	NULL

In	NULL
thymus	NULL
,	NULL
the	NULL
antibody	NULL
strongly	NULL
hybridized	NULL
with	NULL
proteins	NULL
in	NULL
the	NULL
110-130-kDa	NULL
molecular	NULL
mass	NULL
range	NULL
,	NULL
NFAT	NULL
,	NULL
Dephosphorylation	NULL
and	NULL
Nuclear	NULL
Localization	NULL
suggesting	NULL
protein	NULL
heterogeneity	NULL
,	NULL
while	NULL
in	NULL
spleen	NULL
tissue	NULL
,	NULL
reactivity	NULL
was	NULL
predominantly	NULL
against	NULL
a	NULL
110-kDa	NULL
protein	NULL
.	NULL

In	NULL
both	NULL
these	NULL
tissues	NULL
,	NULL
reactivity	NULL
with	NULL
smaller	NULL
proteins	NULL
of	NULL
72	NULL
,	NULL
66	NULL
,	NULL
and	NULL
59	NULL
kDa	NULL
was	NULL
observed	NULL
.	NULL

It	NULL
is	NULL
unknown	NULL
whether	NULL
these	NULL
proteins	NULL
are	NULL
proteolytic	NULL
fragments	NULL
of	NULL
the	NULL
larger	NULL
NFAT	NULL
,	NULL
protein	NULL
.	NULL

However	NULL
,	NULL
in	NULL
competition	NULL
experiments	NULL
in	NULL
which	NULL
the	NULL
NFAT	NULL
,	NULL
peptide	NULL
was	NULL
included	NULL
in	NULL
the	NULL
antibody	NULL
incubation	NULL
,	NULL
no	NULL
reactivity	NULL
was	NULL
observed	NULL
,	NULL
indicating	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
interactions	NULL
(	NULL
Zanes	NULL
8	NULL
and	NULL
9	NULL
)	NULL
.	NULL

In	NULL
kidney	NULL
and	NULL
liver	NULL
,	NULL
there	NULL
was	NULL
little	NULL
or	NULL
no	NULL
antibody	NULL
reactivity	NULL
against	NULL
proteins	NULL
in	NULL
the	NULL
120-kDa	NULL
range	NULL
.	NULL

Cross-reactivity	NULL
against	NULL
proteins	NULL
of	NULL
66	NULL
and	NULL
72	NULL
kDa	NULL
was	NULL
shared	NULL
among	NULL
kidney	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
thymus	NULL
,	NULL
although	NULL
interestingly	NULL
,	NULL
in	NULL
spleen	NULL
and	NULL
thymus	NULL
,	NULL
reactivity	NULL
against	NULL
the	NULL
66-kDa	NULL
protein	NULL
was	NULL
predominant	NULL
,	NULL
while	NULL
in	NULL
kidney	NULL
,	NULL
antibody	NULL
reactivity	NULL
was	NULL
greater	NULL
against	NULL
the	NULL
72-kDa	NULL
protein	NULL
,	NULL
compared	NULL
with	NULL
the	NULL
66-kDa	NULL
protein	NULL
.	NULL

Expression	NULL
of	NULL
NFAT	NULL
,	NULL
was	NULL
very	NULL
low	NULL
in	NULL
brain	NULL
,	NULL
while	NULL
in	NULL
heart	NULL
no	NULL
NFAT	NULL
,	NULL
was	NULL
detected	NULL
.	NULL

The	NULL
high	NULL
level	NULL
of	NULL
NFAT	NULL
,	NULL
expression	NULL
in	NULL
spleen	NULL
and	NULL
thymus	NULL
is	NULL
consistent	NULL
with	NULL
previous	NULL
reports	NULL
demonstrating	NULL
NFAT	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Various	NULL
T	NULL
cell	NULL
lines	NULL
were	NULL
profiled	NULL
to	NULL
investigate	NULL
whether	NULL
NFAT	NULL
,	NULL
levels	NULL
differ	NULL
among	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Peripheral	NULL
blood	NULL
lymphocytes	NULL
had	NULL
the	NULL
lowest	NULL
level	NULL
of	NULL
NFAT	NULL
,	NULL
expression	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
.	NULL

These	NULL
results	NULL
could	NULL
not	NULL
simply	NULL
be	NULL
explained	NULL
by	NULL
a	NULL
lack	NULL
of	NULL
reactivity	NULL
of	NULL
the	NULL
murine	NULL
peptide-derived	NULL
antibody	NULL
against	NULL
human	NULL
protein	NULL
,	NULL
since	NULL
human	NULL
T	NULL
cell	NULL
Jurkat	NULL
cells	NULL
showed	NULL
significant	NULL
reactivity	NULL
with	NULL
the	NULL
antibody	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

HSB	NULL
cells	NULL
,	NULL
a	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
,	NULL
also	NULL
expressed	NULL
the	NULL
approximately	NULL
140-kDa	NULL
NFAT	NULL
,	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
.	NULL

In	NULL
EL-4	NULL
cells	NULL
,	NULL
a	NULL
mouse	NULL
thy-moma	NULL
cell	NULL
line	NULL
,	NULL
NFAT	NULL
,	NULL
was	NULL
expressed	NULL
,	NULL
but	NULL
the	NULL
protein	NULL
was	NULL
more	NULL
heterogeneous	NULL
,	NULL
since	NULL
proteins	NULL
from	NULL
120	NULL
to	NULL
140	NULL
kDa	NULL
reacted	NULL
with	NULL
the	NULL
antibody	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
.	NULL

HT-2	NULL
cells	NULL
,	NULL
an	NULL
IL-2-dependent	NULL
mouse	NULL
T	NULL
cell	NULL
line	NULL
,	NULL
had	NULL
the	NULL
highest	NULL
level	NULL
of	NULL
NFAT	NULL
,	NULL
expression	NULL
compared	NULL
with	NULL
the	NULL
other	NULL
cell	NULL
lines	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
.	NULL

In	NULL
the	NULL
experiment	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lysate	NULL
from	NULL
2.5	NULL
X	NULL
10°	NULL
HT-2	NULL
cells	NULL
resulted	NULL
in	NULL
a	NULL
comparable	NULL
or	NULL
greater	NULL
signal	NULL
,	NULL
compared	NULL
with	NULL
the	NULL
other	NULL
cell	NULL
lines	NULL
,	NULL
in	NULL
which	NULL
4-fold	NULL
more	NULL
cell	NULL
equivalents	NULL
(	NULL
1	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
used	NULL
.	NULL

In	NULL
all	NULL
of	NULL
the	NULL
cell	NULL
lines	NULL
,	NULL
cross-reactivity	NULL
with	NULL
a	NULL
66-kDa	NULL
protein	NULL
was	NULL
seen	NULL
,	NULL
suggesting	NULL
,	NULL
as	NULL
in	NULL
the	NULL
tissue	NULL
samples	NULL
,	NULL
that	NULL
other	NULL
NFAT	NULL
,	NULL
protein	NULL
forms	NULL
may	NULL
be	NULL
expressed	NULL
.	NULL

Competition	NULL
experiments	NULL
using	NULL
NFAT	NULL
,	NULL
peptide	NULL
and	NULL
EL-4	NULL
or	NULL
HT-2	NULL
cell	NULL
extracts	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
demonstrated	NULL
that	NULL
all	NULL
the	NULL
reactivity	NULL
could	NULL
be	NULL
competed	NULL
by	NULL
excess	NULL
peptide	NULL
.	NULL

No	NULL
NFAT	NULL
protein	NULL
was	NULL
detected	NULL
in	NULL
MOLT-4	NULL
cells	NULL
,	NULL
a	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
line	NULL
or	NULL
in	NULL
NIH	NULL
3T3	NULL
cell	NULL
fibroblasts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
T	NULL
cells	NULL
by	NULL
treatment	NULL
with	NULL
PMA	NULL
and	NULL
calcium	NULL
ionophore	NULL
stimulates	NULL
NFAT	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
2	NULL
)	NULL
.	NULL

The	NULL
NFAT	NULL
,	NULL
antibody	NULL
was	NULL
used	NULL
to	NULL
investigate	NULL
directly	NULL
the	NULL
effect	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
on	NULL
NFAT	NULL
protein	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

For	NULL
these	NULL
and	NULL
subsequent	NULL
experiments	NULL
,	NULL
HT-2	NULL
cells	NULL
were	NULL
used	NULL
,	NULL
due	NULL
to	NULL
their	NULL
high	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
NFAT	NULL
,	NULL
.	NULL

NFAT	NULL
,	NULL
migrated	NULL
as	NULL
an	NULL
approximately	NULL
120-kDa	NULL
protein	NULL
in	NULL
untreated	NULL
cells	NULL
.	NULL

Treatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
either	NULL
ionomycin	NULL
alone	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
or	NULL
the	NULL
combination	NULL
of	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
resulted	NULL
in	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
molecular	NULL
weight	NULL
of	NULL
NFAT	NULL
,	NULL
suggestive	NULL
of	NULL
a	NULL
proteolytic	NULL
and/or	NULL
dephosphorylation	NULL
event	NULL
.	NULL

Identical	NULL
shifts	NULL
in	NULL
the	NULL
NFAT	NULL
,	NULL
protein	NULL
were	NULL
observed	NULL
when	NULL
the	NULL
cell	NULL
treatments	NULL
and	NULL
lysate	NULL
preparation	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
panel	NULL
of	NULL
protease	NULL
inhibitors	NULL
,	NULL
including	NULL
leupeptin	NULL
,	NULL
phenyImethylsulfo-nyl	NULL
fluoride	NULL
,	NULL
and	NULL
1-chloro-3-tosylamido-7-amino-2-heptanone	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
mobility	NULL
shift	NULL
was	NULL
not	NULL
the	NULL
result	NULL
of	NULL
proteolysis	NULL
.	NULL

The	NULL
predominant	NULL
NFAT	NULL
,	NULL
protein	NULL
band	NULL
in	NULL
the	NULL
ionomycin-treated	NULL
cells	NULL
was	NULL
approximately	NULL
110	NULL
kDa	NULL
,	NULL
although	NULL
the	NULL
protein	NULL
was	NULL
heterogenous	NULL
in	NULL
size	NULL
.	NULL

Pretreatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
500	NULL
nm	NULL
FK506	NULL
blocked	NULL
the	NULL
ionomycin-induced	NULL
shift	NULL
in	NULL
NFAT	NULL
,	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
,	NULL
suggesting	NULL
a	NULL
role	NULL
for	NULL
CaN	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
rapamycin	NULL
prior	NULL
to	NULL
ionomycin	NULL
treat	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
NFAT	NULL
,	NULL
Dephosphorylation	NULL
and	NULL
Nuclear	NULL
Localization	NULL
0	NULL
&	NULL
5	NULL
§0g	NULL
8	NULL
.	NULL

,	NULL
$	NULL
0	NULL
a	NULL
%	NULL
50g	NULL
8	NULL
1	NULL
o	NULL
8	NULL
i-	NULL
§	NULL
'	NULL
a	NULL
®	NULL
B	NULL
<	NULL
paagp	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Ionomycin	NULL
treatment	NULL
of	NULL
HT-2	NULL
cells	NULL
results	NULL
in	NULL
NFAT	NULL
,	NULL
dephosphorylation	NULL
.	NULL

A	NULL
and	NULL
B	NULL
,	NULL
HT-2	NULL
cells	NULL
were	NULL
treated	NULL
and	NULL
lysates	NULL
were	NULL
prepared	NULL
for	NULL
Western	NULL
blotting	NULL
(	NULL
A	NULL
)	NULL
,	NULL
or	NULL
NFAT	NULL
,	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
*°P-labeled	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

Lane	NULL
1	NULL
,	NULL
control	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
2	NULL
uM	NULL
ionomycin	NULL
for	NULL
10	NULL
min	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
500	NULL
nM	NULL
FK506	NULL
pretreatment	NULL
(	NULL
1	NULL
h	NULL
)	NULL
followed	NULL
by	NULL
2	NULL
um	NULL
ionomycin	NULL
for	NULL
10	NULL
min	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
1	NULL
uM	NULL
rapamycin	NULL
pretreatment	NULL
(	NULL
1	NULL
h	NULL
)	NULL
followed	NULL
by	NULL
ionomycin	NULL
for	NULL
10	NULL
min	NULL
.	NULL

ment	NULL
.	NULL

Rapamycin	NULL
binds	NULL
to	NULL
FKBP-12	NULL
,	NULL
but	NULL
unlike	NULL
FK506	NULL
,	NULL
it	NULL
does	NULL
not	NULL
inhibit	NULL
CaN	NULL
,	NULL
nor	NULL
does	NULL
it	NULL
inhibit	NULL
NFAT	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

Rapamycin	NULL
pretreatment	NULL
also	NULL
did	NULL
not	NULL
block	NULL
the	NULL
NFAT	NULL
,	NULL
mobility	NULL
shift	NULL
induced	NULL
by	NULL
ionomycin	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
changes	NULL
in	NULL
NFAT	NULL
,	NULL
mobility	NULL
were	NULL
the	NULL
result	NULL
of	NULL
ionomycin-induced	NULL
dephosphorylation	NULL
,	NULL
°°P	NULL
labeling	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
32P	NULL
]	NULL
orthophosphate	NULL
for	NULL
4	NULL
h	NULL
followed	NULL
by	NULL
treatments	NULL
similar	NULL
to	NULL
those	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
and	NULL
immunoprecipitation	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
the	NULL
NFAT	NULL
,	NULL
antibody	NULL
.	NULL

A	NULL
similar	NULL
decrease	NULL
in	NULL
molecular	NULL
weight	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
°°P-labeled	NULL
NFAT	NULL
,	NULL
following	NULL
ionomycin	NULL
treatment	NULL
as	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
Western	NULL
blot	NULL
experiments	NULL
.	NULL

Quantitation	NULL
of	NULL
the	NULL
°°P	NULL
autoradiograms	NULL
showed	NULL
that	NULL
ionomycin	NULL
treatment	NULL
resulted	NULL
in	NULL
an	NULL
approximately	NULL
65	NULL
%	NULL
loss	NULL
in	NULL
°°P	NULL
from	NULL
NFAT	NULL
,	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
ionomycin	NULL
treatment	NULL
never	NULL
resulted	NULL
in	NULL
a	NULL
complete	NULL
loss	NULL
of	NULL
°°P	NULL
from	NULL
NFAT	NULL
,	NULL
indicating	NULL
that	NULL
complete	NULL
dephosphorylation	NULL
did	NULL
not	NULL
occur	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
FK506	NULL
inhibited	NULL
the	NULL
loss	NULL
of	NULL
°°P	NULL
,	NULL
while	NULL
rapamycin	NULL
had	NULL
no	NULL
effect	NULL
.	NULL

The	NULL
results	NULL
of	NULL
these	NULL
experiments	NULL
demonstrate	NULL
directly	NULL
that	NULL
the	NULL
shift	NULL
in	NULL
molecular	NULL
weight	NULL
following	NULL
ionomycin	NULL
treatment	NULL
was	NULL
the	NULL
result	NULL
of	NULL
NFAT	NULL
,	NULL
dephosphorylation	NULL
and	NULL
that	NULL
FK506	NULL
pretreatment	NULL
blocked	NULL
the	NULL
dephosphorylation	NULL
.	NULL

A	NULL
role	NULL
for	NULL
CaN	NULL
in	NULL
the	NULL
ionomycin-stimulated	NULL
dephosphorylation	NULL
of	NULL
NFAT	NULL
,	NULL
,	NULL
was	NULL
shown	NULL
directly	NULL
in	NULL
immune	NULL
complex	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

NFAT	NULL
,	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
untreated	NULL
HT-2	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
immunoprecipitates	NULL
were	NULL
washed	NULL
and	NULL
incubated	NULL
with	NULL
CaN	NULL
.	NULL

CaN	NULL
dephosphorylated	NULL
NFAT	NULL
,	NULL
in	NULL
vitro	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
NFAT	NULL
,	NULL
molecular	NULL
weight	NULL
,	NULL
which	NULL
was	NULL
comparable	NULL
to	NULL
the	NULL
molecular	NULL
weight	NULL
shift	NULL
resulting	NULL
from	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
ionomycin	NULL
(	NULL
compare	NULL
Zanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

CaN	NULL
contains	NULL
an	NULL
autoinhibitory	NULL
domain	NULL
in	NULL
its	NULL
COOH-terminal	NULL
domain	NULL
,	NULL
and	NULL
a	NULL
peptide	NULL
from	NULL
this	NULL
region	NULL
inhibits	NULL
CaN	NULL
dephosphorylation	NULL
of	NULL
a	NULL
cAMP-dependent	NULL
protein	NULL
kinase	NULL
peptide	NULL
in	NULL
vitro	NULL
(	NULL
Ref	NULL
.	NULL

22	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
the	NULL
autoinhibitory	NULL
peptide	NULL
to	NULL
the	NULL
immune	NULL
complex	NULL
assay	NULL
blocked	NULL
the	NULL
dephosphorylation	NULL
of	NULL
NFAT	NULL
,	NULL
by	NULL
CaN	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
treatment	NULL
of	NULL
the	NULL
precipitated	NULL
NFAT	NULL
,	NULL
with	NULL
another	NULL
serine/threonine	NULL
phosphatase	NULL
,	NULL
PP2A	NULL
,	NULL
resulted	NULL
in	NULL
little	NULL
or	NULL
no	NULL
dephosphorylation	NULL
of	NULL
NFAT	NULL
,	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
,	NULL
although	NULL
the	NULL
enzyme	NULL
readily	NULL
dephosphorylated	NULL
4-methylumbelliferryl	NULL
phosphate	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
tyrosine	NULL
phosphatase	NULL
PTP1	NULL
also	NULL
did	NULL
not	NULL
dephosphorylate	NULL
NFAT	NULL
,	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
NFAT	NULL
,	NULL
may	NULL
not	NULL
contain	NULL
phosphorylated	NULL
tyrosine	NULL
residues	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
hypothesis	NULL
was	NULL
the	NULL
observation	NULL
that	NULL
there	NULL
was	NULL
no	NULL
reactivity	NULL
on	NULL
Western	NULL
blots	NULL
of	NULL
an-tiphosphotyrosine	NULL
antibodies	NULL
with	NULL
NFAT	NULL
,	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Taken	NULL
22605	NULL
A	NULL
B	NULL
220	NULL
-	NULL
220	NULL
+	NULL
-	NULL
»	NULL
dth	NULL
_	NULL
.	NULL

‘	NULL
-oke	NULL
w	NULL
%	NULL
ene	NULL
«	NULL
am	NULL
-	NULL
C	NULL
97.4	NULL
-/	NULL
w	NULL
a	NULL
»	NULL
sane	NULL
Sg	NULL
®	NULL
97.4	NULL
dines	NULL
66	NULL
66	NULL
46	NULL
F	NULL
e	NULL
wE	NULL
``	NULL
_	NULL
10	NULL
2	NULL
8	NULL
40	NULL
50060	NULL
To	NULL
8s	NULL
I	NULL
-	NULL
%	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Immunocomplex	NULL
phosphatase	NULL
assay	NULL
and	NULL
phosphotyrosine	NULL
blot	NULL
.	NULL

A	NULL
,	NULL
immunocomplex	NULL
phosphatase	NULL
assay	NULL
.	NULL

Immunoprecipitates	NULL
from	NULL
untreated	NULL
cells	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
and	NULL
ionomycin-treated	NULL
cells	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
prepared	NULL
from	NULL
untreated	NULL
cells	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
``	NULL
and	NULL
incubated	NULL
with	NULL
the	NULL
following	NULL
:	NULL
50	NULL
nm	NULL
CaN	NULL
plus	NULL
200	NULL
nM	NULL
calmodulin	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
,	NULL
50	NULL
nm	NULL
CaN	NULL
,	NULL
200	NULL
nM	NULL
calmodulin	NULL
and	NULL
500	NULL
pM	NULL
autoinhibitory	NULL
peptide	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
0.1	NULL
units	NULL
PP2a	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
PP2a	NULL
plus	NULL
500	NULL
nM	NULL
okadaic	NULL
acid	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
PTP	NULL
!	NULL

(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
and	NULL
50	NULL
nm	NULL
CaN	NULL
and	NULL
200	NULL
nM	NULL
calmodulin	NULL
(	NULL
Zane	NULL
8	NULL
)	NULL
,	NULL
developed	NULL
with	NULL
second	NULL
antibody	NULL
alone	NULL
.	NULL

The	NULL
thick	NULL
arrow	NULL
points	NULL
to	NULL
the	NULL
phosphorylated	NULL
form	NULL
of	NULL
NFAT	NULL
,	NULL
and	NULL
the	NULL
thin	NULL
arrow	NULL
points	NULL
to	NULL
the	NULL
dephosphorylated	NULL
form	NULL
.	NULL

B	NULL
,	NULL
phosphotyrosine	NULL
blot	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
HT-2	NULL
cell	NULL
lysate	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
A431	NULL
cell	NULL
lysate	NULL
.	NULL

The	NULL
~170-kDa	NULL
epidermal	NULL
growth	NULL
factor	NULL
receptor	NULL
is	NULL
shown	NULL
in	NULL
lane	NULL
2	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
for	NULL
the	NULL
phosphotyrosine	NULL
antibody	NULL
.	NULL

together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
NFAT	NULL
,	NULL
readily	NULL
serves	NULL
as	NULL
an	NULL
in	NULL
vitro	NULL
substrate	NULL
for	NULL
CaN	NULL
.	NULL

Previous	NULL
studies	NULL
demonstrated	NULL
that	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
is	NULL
accompanied	NULL
by	NULL
an	NULL
increase	NULL
in	NULL
nuclear	NULL
NFAT	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

Using	NULL
the	NULL
NFAT	NULL
,	NULL
antibody	NULL
,	NULL
we	NULL
showed	NULL
directly	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
NFAT	NULL
,	NULL
protein	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
stimulated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

In	NULL
untreated	NULL
cells	NULL
,	NULL
all	NULL
of	NULL
the	NULL
NFAT	NULL
,	NULL
protein	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
low	NULL
speed	NULL
supernatant	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Following	NULL
a	NULL
10-min	NULL
ionomycin	NULL
treatment	NULL
,	NULL
however	NULL
,	NULL
the	NULL
lower	NULL
molecular	NULL
weight	NULL
,	NULL
dephosphorylated	NULL
form	NULL
of	NULL
NFAT	NULL
,	NULL
was	NULL
predominantly	NULL
localized	NULL
to	NULL
the	NULL
nuclear	NULL
fraction	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
.	NULL

Pretreatment	NULL
of	NULL
cells	NULL
with	NULL
FK506	NULL
prior	NULL
to	NULL
ionomycin	NULL
stimulation	NULL
blocked	NULL
the	NULL
dephosphorylation	NULL
,	NULL
as	NULL
previously	NULL
observed	NULL
,	NULL
and	NULL
also	NULL
blocked	NULL
the	NULL
translocation	NULL
of	NULL
NFATp	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
compare	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
time	NULL
course	NULL
for	NULL
NFAT	NULL
,	NULL
dephosphorylation	NULL
and	NULL
nuclear	NULL
localization	NULL
was	NULL
examined	NULL
in	NULL
more	NULL
detail	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Fractionation	NULL
of	NULL
cells	NULL
immediately	NULL
following	NULL
the	NULL
addition	NULL
of	NULL
ionomycin	NULL
indicated	NULL
that	NULL
NFAT	NULL
,	NULL
dephosphorylation	NULL
was	NULL
rapid	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
ladder	NULL
of	NULL
protein	NULL
bands	NULL
.	NULL

After	NULL
ionomycin	NULL
treatment	NULL
for	NULL
10	NULL
min	NULL
,	NULL
the	NULL
dephosphorylated	NULL
NFAT	NULL
,	NULL
was	NULL
present	NULL
in	NULL
both	NULL
the	NULL
low	NULL
speed	NULL
supernatant	NULL
and	NULL
the	NULL
nuclear	NULL
fractions	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
NFAT	NULL
,	NULL
is	NULL
dephosphorylated	NULL
in	NULL
the	NULL
cytosol	NULL
,	NULL
followed	NULL
by	NULL
localization	NULL
of	NULL
the	NULL
dephosphorylated	NULL
form	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

With	NULL
increasing	NULL
time	NULL
of	NULL
incubation	NULL
with	NULL
ionomycin	NULL
,	NULL
dephosphorylated	NULL
NFAT	NULL
,	NULL
was	NULL
present	NULL
almost	NULL
exclusively	NULL
in	NULL
the	NULL
nuclear	NULL
fraction	NULL
,	NULL
although	NULL
a	NULL
small	NULL
level	NULL
of	NULL
dephosphorylated	NULL
NFAT	NULL
,	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
supernatant	NULL
throughout	NULL
the	NULL
4-h	NULL
time	NULL
course	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
NFAT	NULL
,	NULL
is	NULL
rapidly	NULL
dephosphorylated	NULL
and	NULL
localized	NULL
to	NULL
the	NULL
nucleus	NULL
following	NULL
ionomycin	NULL
treatment	NULL
and	NULL
that	NULL
the	NULL
dephosphorylated	NULL
NFAT	NULL
,	NULL
remains	NULL
in	NULL
the	NULL
nucleus	NULL
in	NULL
the	NULL
continuing	NULL
presence	NULL
of	NULL
ionomycin	NULL
.	NULL

A	NULL
similar	NULL
localization	NULL
experiment	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
cells	NULL
pretreated	NULL
with	NULL
ionomycin	NULL
,	NULL
followed	NULL
by	NULL
removal	NULL
of	NULL
the	NULL
ionomycin	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

At	NULL
the	NULL
start	NULL
of	NULL
the	NULL
experiment	NULL
,	NULL
following	NULL
a	NULL
10	NULL
min	NULL
treatment	NULL
with	NULL
ionomycin	NULL
,	NULL
essentially	NULL
all	NULL
of	NULL
the	NULL
NFAT	NULL
,	NULL
was	NULL
localized	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
and	NULL
the	NULL
nuclear	NULL
NFAT	NULL
,	NULL
was	NULL
in	NULL
the	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
22606	NULL
o	NULL
o	NULL
<	NULL
&	NULL
_	NULL
£	NULL
_	NULL
2	NULL
S	NULL
$	NULL
$	NULL
€	NULL
§	NULL
g	NULL
B	NULL
f	NULL
:	NULL
®	NULL
A	NULL
80	NULL
S	NULL
E	NULL
S8	NULL
s	NULL
#	NULL
-	NULL
as	NULL
_	NULL
®	NULL
cie	NULL
Syms	NULL
a	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5°	NULL
6	NULL
low	NULL
speed	NULL
supernatant	NULL
B	NULL
nuclear	NULL
lysate	NULL
__	NULL
|	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
low	NULL
speed	NULL
supernatant	NULL
C	NULL
[	NULL
1	NULL
wore	NULL
0	NULL
cam	NULL
._	NULL
«	NULL
o	NULL
«	NULL
o	NULL
«	NULL
»	NULL
am	NULL
t	NULL
nuclear	NULL
lysate	NULL
cme	NULL
0	NULL
0	NULL
*	NULL
ﬂ	NULL
unul	NULL
.	NULL

moos	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

NFAT	NULL
,	NULL
is	NULL
localized	NULL
to	NULL
the	NULL
nucleus	NULL
in	NULL
ionomycin-treated	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
HT-2	NULL
cells	NULL
were	NULL
treated	NULL
,	NULL
and	NULL
soluble	NULL
and	NULL
nuclear	NULL
fractions	NULL
were	NULL
prepared	NULL
and	NULL
Western-blotted	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

Lanes	NULL
1-3	NULL
are	NULL
soluble	NULL
fractions	NULL
,	NULL
and	NULL
lanes	NULL
4-6	NULL
are	NULL
nuclear	NULL
fractions	NULL
.	NULL

Lanes	NULL
1	NULL
and	NULL
4	NULL
,	NULL
control	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
,	NULL
2	NULL
um	NULL
ionomycin	NULL
for	NULL
10	NULL
min	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
,	NULL
500	NULL
nM	NULL
FK506	NULL
pretreatment	NULL
(	NULL
1	NULL
h	NULL
)	NULL
followed	NULL
by	NULL
ionomycin	NULL
for	NULL
10	NULL
min	NULL
.	NULL

B	NULL
,	NULL
extended	NULL
ionomycin	NULL
time	NULL
course	NULL
;	NULL
C	NULL
,	NULL
ionomycin	NULL
washout	NULL
time	NULL
course	NULL
.	NULL

For	NULL
the	NULL
experiment	NULL
shown	NULL
in	NULL
panel	NULL
B	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
2	NULL
pM	NULL
ionomycin	NULL
,	NULL
and	NULL
the	NULL
zero	NULL
time	NULL
aliquot	NULL
(	NULL
1	NULL
x	NULL
10°	NULL
cells	NULL
)	NULL
was	NULL
removed	NULL
immediately	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
ionomycin	NULL
.	NULL

For	NULL
the	NULL
experiment	NULL
shown	NULL
in	NULL
panel	NULL
C	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
2	NULL
uM	NULL
ionomycin	NULL
for	NULL
10	NULL
min	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
PBS	NULL
and	NULL
resuspended	NULL
at	NULL
2	NULL
10°	NULL
cells/ml	NULL
in	NULL
normal	NULL
growth	NULL
medium	NULL
,	NULL
and	NULL
an	NULL
aliquot	NULL
(	NULL
1	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
was	NULL
removed	NULL
immediately	NULL
for	NULL
the	NULL
zero	NULL
time	NULL
point	NULL
.	NULL

Lanes	NULL
1	NULL
and	NULL
2	NULL
contain	NULL
lysate	NULL
prepared	NULL
from	NULL
2.5	NULL
X	NULL
10°	NULL
cells	NULL
from	NULL
untreated	NULL
or	NULL
ionomycin-treated	NULL
cells	NULL
,	NULL
respectively	NULL
,	NULL
as	NULL
controls	NULL
.	NULL

Supernatant	NULL
(	NULL
upper	NULL
part	NULL
)	NULL
and	NULL
nuclei	NULL
(	NULL
Zower	NULL
part	NULL
)	NULL
are	NULL
shown	NULL
from	NULL
untreated	NULL
cells	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
and	NULL
cells	NULL
treated	NULL
with	NULL
ionomycin	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
:	NULL
0	NULL
time	NULL
(	NULL
Zame	NULL
4	NULL
)	NULL
,	NULL
10	NULL
min	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
30	NULL
min	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
1	NULL
h	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
2	NULL
h	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
,	NULL
3	NULL
h	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
,	NULL
and	NULL
4	NULL
h	NULL
{	NULL
lane	NULL
10	NULL
)	NULL
.	NULL

lower	NULL
molecular	NULL
weight	NULL
,	NULL
dephosphorylated	NULL
form	NULL
.	NULL

After	NULL
10	NULL
min	NULL
following	NULL
washout	NULL
of	NULL
the	NULL
ionomycin	NULL
,	NULL
NFAT	NULL
,	NULL
was	NULL
still	NULL
in	NULL
the	NULL
nuclear	NULL
fraction	NULL
,	NULL
although	NULL
a	NULL
low	NULL
level	NULL
of	NULL
the	NULL
higher	NULL
molecular	NULL
weight	NULL
,	NULL
phosphorylated	NULL
form	NULL
of	NULL
NFAT	NULL
,	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
low	NULL
speed	NULL
supernatant	NULL
.	NULL

However	NULL
,	NULL
at	NULL
the	NULL
30-min	NULL
time	NULL
point	NULL
and	NULL
beyond	NULL
,	NULL
NFAT	NULL
,	NULL
was	NULL
localized	NULL
in	NULL
the	NULL
low	NULL
speed	NULL
supernatant	NULL
fraction	NULL
,	NULL
with	NULL
no	NULL
detectable	NULL
NFAT	NULL
,	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
following	NULL
ionomycin	NULL
washout	NULL
,	NULL
NFAT	NULL
,	NULL
is	NULL
recycled	NULL
from	NULL
the	NULL
nucleus	NULL
back	NULL
into	NULL
the	NULL
cytosol	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
NFAT	NULL
,	NULL
in	NULL
the	NULL
low	NULL
speed	NULL
supernatant	NULL
was	NULL
exclusively	NULL
in	NULL
the	NULL
higher	NULL
molecular	NULL
weight	NULL
,	NULL
phosphorylated	NULL
form	NULL
,	NULL
suggesting	NULL
that	NULL
migration	NULL
from	NULL
the	NULL
nucleus	NULL
was	NULL
accompanied	NULL
by	NULL
rapid	NULL
rephos-phorylation	NULL
of	NULL
NFAT	NULL
.	NULL

Loss	NULL
of	NULL
NFAT	NULL
,	NULL
from	NULL
the	NULL
nuclear	NULL
fraction	NULL
could	NULL
result	NULL
from	NULL
NFAT	NULL
,	NULL
degradation	NULL
.	NULL

To	NULL
investigate	NULL
this	NULL
possibility	NULL
,	NULL
[	NULL
°SImethi-	NULL
NFAT	NULL
,	NULL
Dephosphorylation	NULL
and	NULL
Nuclear	NULL
Localization	NULL
A	NULL
10°	NULL
[	NULL
Counts	NULL
0	NULL
6	NULL
12	NULL
18	NULL
24	NULL
Time	NULL
,	NULL
hrs	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

[	NULL
**S	NULL
)	NULL
methionine	NULL
labeling	NULL
experiments	NULL
.	NULL

A	NULL
,	NULL
degradation	NULL
.	NULL

The	NULL
data	NULL
points	NULL
shown	NULL
are	NULL
the	NULL
mean	NULL
+	NULL
S.E	NULL
.	NULL

of	NULL
three	NULL
experiments	NULL
.	NULL

HT-2	NULL
cells	NULL
were	NULL
labeled	NULL
and	NULL
treated	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

O	NULL
,	NULL
control	NULL
;	NULL
@	NULL
,	NULL
ionomycin	NULL
;	NULL
¥	NULL
,	NULL
FK506	NULL
plus	NULL
ionomycin	NULL
.	NULL

The	NULL
inset	NULL
shows	NULL
a	NULL
representative	NULL
autorad	NULL
from	NULL
untreated	NULL
cells	NULL
.	NULL

B	NULL
,	NULL
pulse-chase	NULL
experiment	NULL
.	NULL

Lanes	NULL
1-3	NULL
,	NULL
immunoprecipitates	NULL
from	NULL
untreated	NULL
cells	NULL
;	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
,	NULL
immunoprecipitates	NULL
from	NULL
ionomycin-treated	NULL
cells	NULL
;	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
,	NULL
0	NULL
time	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
,	NULL
10	NULL
min	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
20	NULL
min	NULL
.	NULL

onine	NULL
labeling	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
to	NULL
measure	NULL
the	NULL
half-life	NULL
of	NULL
the	NULL
NFAT	NULL
,	NULL
protein	NULL
.	NULL

Cells	NULL
were	NULL
labeled	NULL
overnight	NULL
with	NULL
[	NULL
°°SJmethionine	NULL
and	NULL
then	NULL
chased	NULL
in	NULL
medium	NULL
containing	NULL
unlabeled	NULL
methionine	NULL
.	NULL

The	NULL
rate	NULL
of	NULL
loss	NULL
of	NULL
immunoprecipitated	NULL
NFAT	NULL
,	NULL
was	NULL
determined	NULL
for	NULL
untreated	NULL
,	NULL
ionomycin-treated	NULL
,	NULL
and	NULL
FK506-	NULL
and	NULL
ionomycin-treated	NULL
cells	NULL
,	NULL
and	NULL
is	NULL
shown	NULL
as	NULL
a	NULL
semi-log	NULL
plot	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

In	NULL
untreated	NULL
cells	NULL
the	NULL
¢	NULL
,	NULL
for	NULL
NFAT	NULL
,	NULL
was	NULL
16.9	NULL
+	NULL
0.86	NULL
h	NULL
(	NULL
mean	NULL
+	NULL
S.E	NULL
.	NULL

,	NULL
n	NULL
=	NULL
3	NULL
)	NULL
,	NULL
which	NULL
was	NULL
similar	NULL
to	NULL
the	NULL
value	NULL
obtained	NULL
from	NULL
cells	NULL
treated	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
FK506	NULL
and	NULL
ionomycin	NULL
(	NULL
19.2	NULL
+	NULL
3.9	NULL
h	NULL
)	NULL
.	NULL

Treatment	NULL
with	NULL
ionomycin	NULL
,	NULL
however	NULL
,	NULL
caused	NULL
a	NULL
slight	NULL
decrease	NULL
in	NULL
the	NULL
time	NULL
required	NULL
for	NULL
loss	NULL
of	NULL
50	NULL
%	NULL
of	NULL
the	NULL
prelabeled	NULL
NFAT	NULL
,	NULL
to	NULL
11.9	NULL
+	NULL
2.7	NULL
h.	NULL
These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
loss	NULL
of	NULL
NFAT	NULL
,	NULL
from	NULL
the	NULL
nucleus	NULL
was	NULL
not	NULL
the	NULL
result	NULL
of	NULL
degradation	NULL
of	NULL
the	NULL
protein	NULL
and	NULL
support	NULL
the	NULL
hypothesis	NULL
that	NULL
nuclear	NULL
NFAT	NULL
,	NULL
reappears	NULL
in	NULL
the	NULL
cytosol	NULL
following	NULL
ionomycin	NULL
removal	NULL
.	NULL

During	NULL
short	NULL
labeling	NULL
times	NULL
,	NULL
the	NULL
major	NULL
NFAT	NULL
,	NULL
was	NULL
in	NULL
the	NULL
dephosphorylated	NULL
form	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
this	NULL
form	NULL
was	NULL
rapidly	NULL
chased	NULL
into	NULL
the	NULL
higher	NULL
molecular	NULL
weight	NULL
,	NULL
phosphorylated	NULL
form	NULL
of	NULL
NFAT	NULL
,	NULL
suggesting	NULL
that	NULL
phosphorylation	NULL
of	NULL
NFAT	NULL
,	NULL
occurs	NULL
very	NULL
rapidly	NULL
following	NULL
synthesis	NULL
.	NULL

DISCUSSION	NULL
Much	NULL
of	NULL
the	NULL
available	NULL
information	NULL
concerning	NULL
NFAT	NULL
is	NULL
the	NULL
result	NULL
of	NULL
studies	NULL
of	NULL
NFAT	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
1-3	NULL
,	NULL
9	NULL
,	NULL
11	NULL
)	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
several	NULL
forms	NULL
of	NULL
NFAT	NULL
have	NULL
been	NULL
cloned	NULL
,	NULL
and	NULL
Northern	NULL
analysis	NULL
demonstrated	NULL
that	NULL
NFAT	NULL
mRNA	NULL
levels	NULL
vary	NULL
among	NULL
different	NULL
tissues	NULL
and	NULL
under	NULL
stimulus	NULL
conditions	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Investigations	NULL
with	NULL
a	NULL
specific	NULL
NFAT	NULL
,	NULL
antibody	NULL
allowed	NULL
expansion	NULL
of	NULL
these	NULL
studies	NULL
to	NULL
include	NULL
direct	NULL
analysis	NULL
of	NULL
the	NULL
NFAT	NULL
,	NULL
protein	NULL
.	NULL

The	NULL
peptide	NULL
sequence	NULL
used	NULL
to	NULL
generate	NULL
the	NULL
antibody	NULL
described	NULL
here	NULL
is	NULL
derived	NULL
from	NULL
the	NULL
COOH-terminal	NULL
region	NULL
of	NULL
NFAT	NULL
,	NULL
which	NULL
is	NULL
not	NULL
present	NULL
in	NULL
NFAT	NULL
,	NULL
and	NULL
thus	NULL
the	NULL
antibody	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
NFAT	NULL
,	NULL
Dephosphorylation	NULL
and	NULL
Nuclear	NULL
Localization	NULL
differentiates	NULL
between	NULL
the	NULL
two	NULL
NFAT	NULL
forms	NULL
.	NULL

The	NULL
NFAT	NULL
,	NULL
protein	NULL
was	NULL
highly	NULL
expressed	NULL
in	NULL
thymus	NULL
and	NULL
spleen	NULL
tissue	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
mRNA	NULL
analysis	NULL
(	NULL
7	NULL
)	NULL
.	NULL

However	NULL
,	NULL
Northrup	NULL
et	NULL
al	NULL
.	NULL

(	NULL
7	NULL
)	NULL
reported	NULL
that	NULL
NFAT	NULL
,	NULL
mRNA	NULL
levels	NULL
were	NULL
similar	NULL
in	NULL
brain	NULL
,	NULL
heart	NULL
,	NULL
thymus	NULL
,	NULL
and	NULL
spleen	NULL
,	NULL
while	NULL
our	NULL
immunoblotting	NULL
results	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
showed	NULL
that	NULL
no	NULL
NFAT	NULL
,	NULL
protein	NULL
was	NULL
detected	NULL
in	NULL
heart	NULL
tissue	NULL
,	NULL
and	NULL
only	NULL
very	NULL
low	NULL
levels	NULL
in	NULL
brain	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
NFAT	NULL
,	NULL
mRNA	NULL
may	NULL
not	NULL
predict	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
protein	NULL
in	NULL
all	NULL
tissues	NULL
or	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
lower	NULL
molecular	NULL
weight	NULL
proteins	NULL
reacted	NULL
with	NULL
the	NULL
NFAT	NULL
,	NULL
antibody	NULL
,	NULL
suggesting	NULL
that	NULL
other	NULL
forms	NULL
of	NULL
NFAT	NULL
,	NULL
may	NULL
exist	NULL
.	NULL

Consistent	NULL
with	NULL
these	NULL
results	NULL
is	NULL
the	NULL
report	NULL
that	NULL
COOH-terminal	NULL
splicing	NULL
variants	NULL
of	NULL
NFATp	NULL
have	NULL
been	NULL
cloned	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Peptide	NULL
mapping	NULL
or	NULL
purification	NULL
of	NULL
the	NULL
lower	NULL
molecular	NULL
weight	NULL
,	NULL
cross-reactive	NULL
proteins	NULL
is	NULL
required	NULL
to	NULL
determine	NULL
whether	NULL
they	NULL
are	NULL
related	NULL
to	NULL
NFAT	NULL
.	NULL

Tonomycin	NULL
treatment	NULL
of	NULL
the	NULL
HT-2	NULL
cells	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
shift	NULL
in	NULL
the	NULL
molecular	NULL
weight	NULL
of	NULL
NFAT	NULL
,	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
immunoblotting	NULL
analysis	NULL
.	NULL

The	NULL
°°P	NULL
labeling	NULL
experiments	NULL
provided	NULL
a	NULL
direct	NULL
demonstration	NULL
that	NULL
NFAT	NULL
,	NULL
is	NULL
a	NULL
phosphoprotein	NULL
and	NULL
that	NULL
the	NULL
shift	NULL
in	NULL
molecular	NULL
weight	NULL
resulted	NULL
from	NULL
dephosphorylation	NULL
of	NULL
NFAT	NULL
.	NULL

The	NULL
dephosphorylation-induced	NULL
molecular	NULL
weight	NULL
mass	NULL
was	NULL
approximately	NULL
10	NULL
kDa	NULL
and	NULL
represented	NULL
an	NULL
approximately	NULL
65	NULL
%	NULL
loss	NULL
in	NULL
phosphate	NULL
from	NULL
the	NULL
protein	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
phosphorylation	NULL
of	NULL
NFAT	NULL
,	NULL
is	NULL
not	NULL
known	NULL
,	NULL
and	NULL
the	NULL
results	NULL
shown	NULL
here	NULL
indicate	NULL
that	NULL
dephosphorylation	NULL
results	NULL
in	NULL
a	NULL
significant	NULL
change	NULL
in	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
protein	NULL
on	NULL
SDS-polyacrylamide	NULL
gels	NULL
.	NULL

This	NULL
result	NULL
has	NULL
practical	NULL
applications	NULL
,	NULL
for	NULL
it	NULL
allows	NULL
detection	NULL
of	NULL
the	NULL
phosphorylated	NULL
and	NULL
dephosphorylated	NULL
forms	NULL
of	NULL
NFAT	NULL
,	NULL
using	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

The	NULL
results	NULL
of	NULL
the	NULL
localization	NULL
experiments	NULL
suggest	NULL
that	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
NFAT	NULL
,	NULL
may	NULL
be	NULL
a	NULL
determinant	NULL
of	NULL
its	NULL
localization	NULL
within	NULL
the	NULL
cell	NULL
.	NULL

In	NULL
untreated	NULL
cells	NULL
,	NULL
NFAT	NULL
,	NULL
was	NULL
in	NULL
the	NULL
phosphorylated	NULL
state	NULL
,	NULL
and	NULL
was	NULL
localized	NULL
to	NULL
the	NULL
low	NULL
speed	NULL
supernatant	NULL
.	NULL

However	NULL
,	NULL
in	NULL
ionomycin-treated	NULL
cells	NULL
,	NULL
dephosphorylated	NULL
NFAT	NULL
,	NULL
was	NULL
found	NULL
in	NULL
the	NULL
nuclear	NULL
fraction	NULL
.	NULL

Kinetic	NULL
anal-ysis	NULL
,	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
suggests	NULL
that	NULL
dephosphorylation	NULL
occurs	NULL
prior	NULL
to	NULL
nuclear	NULL
localization	NULL
,	NULL
since	NULL
at	NULL
the	NULL
10-min	NULL
time	NULL
point	NULL
,	NULL
dephosphorylated	NULL
NFAT	NULL
,	NULL
was	NULL
present	NULL
in	NULL
both	NULL
the	NULL
cytosolic	NULL
and	NULL
nuclear	NULL
fractions	NULL
,	NULL
while	NULL
at	NULL
later	NULL
time	NULL
points	NULL
the	NULL
dephosphorylated	NULL
form	NULL
was	NULL
exclusively	NULL
localized	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

As	NULL
long	NULL
as	NULL
ionomycin	NULL
was	NULL
present	NULL
,	NULL
NFAT	NULL
,	NULL
remained	NULL
both	NULL
dephosphorylated	NULL
and	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

Previous	NULL
studies	NULL
demonstrated	NULL
that	NULL
NFAT	NULL
,	NULL
DNA	NULL
binding	NULL
activity	NULL
is	NULL
localized	NULL
to	NULL
the	NULL
cytosol	NULL
of	NULL
untreated	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
to	NULL
the	NULL
nuclear	NULL
fraction	NULL
in	NULL
stimulated	NULL
cells	NULL
(	NULL
3	NULL
)	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
here	NULL
demonstrate	NULL
directly	NULL
that	NULL
the	NULL
shift	NULL
in	NULL
DNA	NULL
binding	NULL
activity	NULL
seen	NULL
by	NULL
others	NULL
reflects	NULL
a	NULL
change	NULL
in	NULL
the	NULL
cellular	NULL
location	NULL
of	NULL
the	NULL
NFAT	NULL
,	NULL
protein	NULL
.	NULL

Following	NULL
ionomycin	NULL
removal	NULL
,	NULL
NFAT	NULL
,	NULL
reappeared	NULL
in	NULL
the	NULL
cell	NULL
supernatant	NULL
fraction	NULL
,	NULL
in	NULL
the	NULL
higher	NULL
molecular	NULL
weight	NULL
,	NULL
phosphorylated	NULL
form	NULL
.	NULL

The	NULL
labeling	NULL
experiments	NULL
demonstrated	NULL
that	NULL
NFAT	NULL
,	NULL
is	NULL
a	NULL
relatively	NULL
stable	NULL
protein	NULL
,	NULL
with	NULL
a	NULL
half-life	NULL
of	NULL
approximately	NULL
17	NULL
h	NULL
in	NULL
untreated	NULL
cells	NULL
and	NULL
approximately	NULL
12	NULL
h	NULL
in	NULL
ionomycin-treated	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
loss	NULL
of	NULL
signal	NULL
from	NULL
the	NULL
nucleus	NULL
following	NULL
ionomycin	NULL
removal	NULL
can	NULL
not	NULL
be	NULL
explained	NULL
by	NULL
degradation	NULL
of	NULL
NFAT	NULL
,	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
NFAT	NULL
,	NULL
may	NULL
shuttle	NULL
in	NULL
and	NULL
out	NULL
of	NULL
the	NULL
nucleus	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
activation	NULL
state	NULL
of	NULL
the	NULL
cell	NULL
as	NULL
well	NULL
as	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

A	NULL
potential	NULL
nuclear	NULL
localization	NULL
sequence	NULL
has	NULL
been	NULL
identified	NULL
within	NULL
the	NULL
Rel	NULL
homology	NULL
region	NULL
of	NULL
NFAT	NULL
,	NULL
(	NULL
23	NULL
)	NULL
.	NULL

There	NULL
are	NULL
a	NULL
number	NULL
of	NULL
potential	NULL
phosphorylation	NULL
sites	NULL
in	NULL
NFAT	NULL
,	NULL
including	NULL
one	NULL
within	NULL
the	NULL
nuclear	NULL
localization	NULL
sequence	NULL
.	NULL

One	NULL
possibility	NULL
is	NULL
that	NULL
activation-induced	NULL
dephosphorylation	NULL
of	NULL
NFAT	NULL
,	NULL
results	NULL
in	NULL
an	NULL
unmasking	NULL
of	NULL
the	NULL
nuclear	NULL
localization	NULL
sequence	NULL
,	NULL
leading	NULL
to	NULL
nuclear	NULL
localization	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

The	NULL
immunocomplex	NULL
assay	NULL
demonstrated	NULL
directly	NULL
that	NULL
22607	NULL
NFAT	NULL
,	NULL
is	NULL
a	NULL
CaN	NULL
substrate	NULL
in	NULL
vitro	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
CaN-induced	NULL
molecular	NULL
weight	NULL
shift	NULL
in	NULL
NFAT	NULL
,	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
resulting	NULL
from	NULL
ionomycin	NULL
treatment	NULL
of	NULL
cells	NULL
.	NULL

Treatment	NULL
of	NULL
intact	NULL
cells	NULL
with	NULL
FK506	NULL
,	NULL
a	NULL
CaN	NULL
inhibitor	NULL
,	NULL
blocks	NULL
the	NULL
ionomycin-induced	NULL
dephosphorylation	NULL
,	NULL
which	NULL
further	NULL
supports	NULL
but	NULL
does	NULL
not	NULL
prove	NULL
the	NULL
hypothesis	NULL
that	NULL
NFAT	NULL
,	NULL
is	NULL
a	NULL
CaN	NULL
substrate	NULL
in	NULL
intact	NULL
cells	NULL
.	NULL

In	NULL
general	NULL
,	NULL
no	NULL
consensus	NULL
sequence	NULL
for	NULL
dephosphorylation	NULL
of	NULL
substrates	NULL
by	NULL
CaN	NULL
has	NULL
been	NULL
identified	NULL
.	NULL

However	NULL
,	NULL
Donella-Deana	NULL
et	NULL
al	NULL
.	NULL

(	NULL
24	NULL
)	NULL
have	NULL
demonstrated	NULL
in	NULL
phosphopeptide	NULL
studies	NULL
that	NULL
basic	NULL
residues	NULL
on	NULL
the	NULL
NH-terminal	NULL
side	NULL
of	NULL
the	NULL
phos-phoamino	NULL
acid	NULL
,	NULL
especially	NULL
at	NULL
the	NULL
-3	NULL
position	NULL
,	NULL
are	NULL
positive	NULL
determinants	NULL
for	NULL
dephosphorylation	NULL
by	NULL
CaN	NULL
,	NULL
while	NULL
acidic	NULL
residues	NULL
on	NULL
the	NULL
COOH-terminal	NULL
side	NULL
are	NULL
negative	NULL
determinants	NULL
.	NULL

Because	NULL
of	NULL
a	NULL
lack	NULL
of	NULL
a	NULL
strong	NULL
consensus	NULL
sequence	NULL
,	NULL
these	NULL
results	NULL
and	NULL
the	NULL
results	NULL
of	NULL
others	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
have	NULL
led	NULL
to	NULL
the	NULL
suggestion	NULL
that	NULL
more	NULL
complex	NULL
protein	NULL
structural	NULL
determinants	NULL
also	NULL
play	NULL
a	NULL
role	NULL
in	NULL
defining	NULL
CaN	NULL
substrate	NULL
specificity	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
a	NULL
number	NULL
of	NULL
sites	NULL
within	NULL
NFAT	NULL
,	NULL
may	NULL
be	NULL
sites	NULL
for	NULL
CaN	NULL
dephosphorylation	NULL
.	NULL

Mapping	NULL
these	NULL
sites	NULL
in	NULL
vitro	NULL
and	NULL
comparing	NULL
them	NULL
with	NULL
the	NULL
sites	NULL
of	NULL
dephosphorylation	NULL
in	NULL
intact	NULL
cells	NULL
is	NULL
required	NULL
to	NULL
establish	NULL
whether	NULL
NFAT	NULL
,	NULL
is	NULL
a	NULL
direct	NULL
substrate	NULL
for	NULL
CaN	NULL
in	NULL
intact	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
of	NULL
such	NULL
experiments	NULL
will	NULL
define	NULL
in	NULL
more	NULL
detail	NULL
the	NULL
exact	NULL
role	NULL
of	NULL
CaN	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Acknowledgments-We	NULL
acknowledge	NULL
Dr.	NULL
Anjana	NULL
Rao	NULL
for	NULL
the	NULL
gift	NULL
of	NULL
Ar-5	NULL
extracts	NULL
,	NULL
Kay	NULL
Petruska	NULL
for	NULL
secretarial	NULL
assistance	NULL
,	NULL
and	NULL
Dr.	NULL
Clark	NULL
Smith	NULL
and	NULL
Carol	NULL
Bannow	NULL
for	NULL
peptide	NULL
synthesis	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Liu	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
14	NULL
,	NULL
290-295	NULL
2	NULL
.	NULL

Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
15	NULL
,	NULL
274-281	NULL
3	NULL
.	NULL

Emmel	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Verweij	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Higgins	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Lacy	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
246	NULL
,	NULL
1617-1620	NULL
4	NULL
.	NULL

Shaw	NULL
,	NULL
J-P.	NULL
,	NULL
Utz	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Toole	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Emmel	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
241	NULL
,	NULL
202-205	NULL
5	NULL
.	NULL

Ullman	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Northrup	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Verweij	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

8	NULL
,	NULL
421-452	NULL
6	NULL
.	NULL

Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Clipstone	NULL
,	NULL
N.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

63	NULL
,	NULL
1045-1083	NULL
7	NULL
.	NULL

Northrup	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Ho	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
Chen	NULL
,	NULL
L.	NULL
,	NULL
Thomas	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Timmerman	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Admon	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
869	NULL
,	NULL
497-502	NULL
8	NULL
.	NULL

McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Luo	NULL
,	NULL
C.	NULL
,	NULL
Kerppola	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
Jain	NULL
,	NULL
J.	NULL
,	NULL
Badalian	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Ho	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Burgeon	NULL
,	NULL
E.	NULL
,	NULL
Lane	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Lambert	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Curran	NULL
,	NULL
T.	NULL
,	NULL
Verdine	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Hogan	NULL
,	NULL
P.	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
750-754	NULL
9	NULL
.	NULL

Flanagan	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
Corthesy	NULL
,	NULL
B.	NULL
,	NULL
Bram	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
852	NULL
,	NULL
803-807	NULL
10	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
Miner	NULL
,	NULL
Z.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

151	NULL
,	NULL
837-848	NULL
11	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Valge-Archer	NULL
,	NULL
V.	NULL
E.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nature	NULL
856	NULL
,	NULL
801-804	NULL
12	NULL
.	NULL

Liu	NULL
,	NULL
J.	NULL
,	NULL
Farmer	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Jr.	NULL
,	NULL
Lane	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Friedman	NULL
,	NULL
J.	NULL
,	NULL
Weissman	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Schreiber	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
66	NULL
,	NULL
807-815	NULL
13	NULL
.	NULL

Friedman	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Weissman	NULL
,	NULL
I	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Cell	NULL
66	NULL
,	NULL
799-806	NULL
14	NULL
.	NULL

Liu	NULL
,	NULL
J.	NULL
,	NULL
Albers	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
Wandless	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Luam	NULL
,	NULL
S.	NULL
,	NULL
Alberg	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Belshaw	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Cohen	NULL
,	NULL
P.	NULL
,	NULL
MacKintosh	NULL
,	NULL
C.	NULL
,	NULL
Klee	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
and	NULL
Schreiber	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
Biochemistry	NULL
31	NULL
,	NULL
3896-3901	NULL
15	NULL
.	NULL

O'Keefe	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Tamurai	NULL
,	NULL
J.	NULL
,	NULL
Kincaid	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Tocci	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
O'Neill	NULL
,	NULL
E.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nature	NULL
857	NULL
,	NULL
692-697	NULL
16	NULL
.	NULL

Clipstone	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Nature	NULL
857	NULL
,	NULL
695-697	NULL
17	NULL
.	NULL

Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Ullman	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
2917-2923	NULL
18	NULL
.	NULL

McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Perrino	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Soderling	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
3747-3752	NULL
19	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Miner	NULL
,	NULL
A.	NULL
,	NULL
Kerppola	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
Lambert	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Verdine	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Curran	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Nature	NULL
865	NULL
,	NULL
352-355	NULL
20	NULL
.	NULL

Ho	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Jain	NULL
,	NULL
J.	NULL
,	NULL
Rao	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Hogan	NULL
,	NULL
P.	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
28181-28186	NULL
21	NULL
.	NULL

Bradford	NULL
,	NULL
M.	NULL
M.	NULL
(	NULL
1976	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

72	NULL
,	NULL
248-254	NULL
22	NULL
.	NULL

Hashimoto	NULL
,	NULL
Y.	NULL
,	NULL
Perrino	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Soderling	NULL
,	NULL
T.	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
1924-1927	NULL
23	NULL
.	NULL

Li	NULL
,	NULL
X.	NULL
,	NULL
Ho	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
Luna	NULL
,	NULL
J.	NULL
,	NULL
Giacalone	NULL
,	NULL
J.	NULL
,	NULL
Thomas	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Timmerman	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Francke	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Cytogenet	NULL
.	NULL

Cell	NULL
Genet	NULL
.	NULL

68	NULL
,	NULL
185-191	NULL
24	NULL
.	NULL

Donella-Deana	NULL
,	NULL
A.	NULL
,	NULL
Krinks	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Ruzzene	NULL
,	NULL
M.	NULL
,	NULL
Klee	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Pinna	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

219	NULL
,	NULL
109-117	NULL
25	NULL
.	NULL

Hemmings	NULL
,	NULL
H.	NULL
C.	NULL
,	NULL
Jr.	NULL
,	NULL
Nairn	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Elliott	NULL
,	NULL
J.	NULL
I.	NULL
,	NULL
and	NULL
Greengard	NULL
,	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
20369-20376	NULL
26	NULL
.	NULL

King	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Huang	NULL
,	NULL
C.	NULL
Y.	NULL
,	NULL
Chock	NULL
,	NULL
P.	NULL
B.	NULL
,	NULL
Nairn	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Hemmings	NULL
,	NULL
H.	NULL
C.	NULL
,	NULL
Jr.	NULL
,	NULL
Chan	NULL
,	NULL
K.	NULL
F.	NULL
,	NULL
and	NULL
Greengard	NULL
,	NULL
P.	NULL
(	NULL
1984	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

259	NULL
,	NULL
8080-8083	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Direct	NULL
Demonstration	NULL
of	NULL
NFAT	NULL
,	NULL
,	NULL
Dephosphorylation	NULL
and	NULL
Nuclear	NULL
Localization	NULL
in	NULL
Activated	NULL
HT-2	NULL
Cells	NULL
Using	NULL
a	NULL
Specific	NULL
NFAT	NULL
,	NULL
,	NULL
Polyclonal	NULL
Antibody	NULL
Valerie	NULL
A.	NULL
Ruff	NULL
and	NULL
Karen	NULL
L.	NULL
Beach	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1995	NULL
,	NULL
270:22602-22607.	NULL
doi	NULL
:	NULL
10.1074/jb0.270.38.22602	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/270/38/22602	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
26	NULL
references	NULL
,	NULL
10	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

